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The Institute of Medicine places the patient at the center of their high-quality cancer care 
conceptual framework, arguing that supporting patient engagement within the cancer setting is 
the highest priority for the improvement of cancer care. Adolescent cancer patients make up a 
unique cancer group due to tumor biology, specific cancer-related challenges, and social and 
cognitive factors unique to this developmental period. Within adolescent oncology, there are two 
main approaches for achieving high-quality care and increased patient engagement – patient-
centered care and family-centered care. The current study examined a sample of 80 adolescent 
cancer patients, and determined how engagement is associated with self-reported quality of care, 
and the moderating roles of models of care, patient age, and development. A cross-sectional 
survey design was utilized, and participants were recruited in-person at two metropolitan 
hospitals. Participants recruited for this study were diagnosed with their most recent cancer 
diagnosis between the ages of 10 and 20, were at least 3 months from their most recent 
diagnosis, and had finished active treatment in the last two years (if they were not currently 
receiving treatment). Overall, the study found no significant relationship between patient 
engagement and quality of care, and models of care and patient’s age and development did not 
moderate this relationship. However, both patient-centered care and cognitive development were 
significant predictors of quality of care. Participants reported experiencing patient-centered care 
more often than family-centered care, but family-centered care was significantly correlated with 
patient engagement. Finally, cognitive development was the only unique, significant predictor of 
patient engagement in the current study. These findings demonstrate the necessity of examining 
Elizabeth Jane Siembida – University of Connecticut, 2016 
adolescent cancer patients as their own unique group. Patient engagement does not play the same 
role in adolescents’ perceptions of quality of care as we see in adults. Future research will need 
to further elucidate what aspects of their experience are important in improving quality of cancer 
care in adolescent cancer patients. The examination of developmental metrics was a novel aspect 
of the current study, and it exemplified the importance of development in adolescent cancer 
patients’ experience, but also the need to examine multiple developmental metrics. 
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Chapter 1 
Introduction and Background 
 A cancer diagnosis at any point in the lifespan has the potential to alter a person’s life 
course trajectory, but when diagnosed during important developmental periods, like adolescence, 
this alteration can be even more pronounced (Bellizzi et al., 2012). Adolescent cancer patients 
are part of the broader adolescent and young adult (AYA) cancer population, defined as those 
individuals diagnosed with cancer between the ages of 15 and 39 (National Cancer Institute 
[NCI], 2006). It is estimated that about 70,000 AYA individuals will be diagnosed with cancer in 
the year 2015 in the United States (NCI, 2014).  
 The focus on AYA cancer patients emerged from a stagnation in long-term survival rates, 
and reports of patients not feeling like they had a “home” within the oncology setting (NCI, 
2006). A number of barriers preventing progress within the AYA cancer population have been 
identified, including access to care, a high rate of uninsured individuals (although this may be 
changing with the implementation of the Affordable Care Act), delayed diagnosis, lack of long-
term follow-up information, lack of available clinical trials, lack of knowledge of the cancers 
common among this age group, inconsistent treatment, and limited psychosocial and support 
services tailored for the AYA population (NCI, 2006).  
In response to these trends, the Progress Review Group assembled by the National 
Cancer Institute (NCI) and LiveStrong (a group focused on the development of healthy lives in 
cancer survivors) suggested that clinicians and researchers consider even narrower definitions of 
this broad, inclusive age range by considering key variables such as tumor biology, physical 
traits, stage of development, and specific cancer-related challenges (NCI, 2006). With both 
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medical and developmental implications of a cancer diagnosis in adolescence, it is important to 
consider this smaller subsample of the broadly defined AYA population. 
 Adolescence is a period of transition from the dependence of childhood to the 
independence of adulthood, and important cognitive and social factors unique to the adolescent 
development period may be important to consider when determining patient engagement and 
quality of care for adolescent cancer patients. Unfortunately, there is not an agreed upon 
definition of “adolescent” within the medical setting, and varying age ranges utilized in different 
definitions have made the current literature on adolescent patients muddled (Louis-Jacques & 
Sample, 2011; Quinn et al., 2011). The lack of a clear definition for “adolescent” and the paucity 
of research on the physical, cognitive, and psychosocial changes specific to this developmental 
period make it difficult for healthcare providers to determine the best way to engage patients and 
provide quality care to this population. What is clear, however, is that a tailored approach is 
likely necessary. 
 National medical organizations in the United States, including the American Society of 
Clinical Oncology (2014) and the Institute of Medicine (2013), have emphasized the importance 
of improving the quality of cancer care in America, and in 2013 the Institute of Medicine 
developed a conceptual framework to describe high quality cancer care across the cancer 
continuum (Institute of Medicine, 2013). A diagram of their framework can be found in 
Appendix A. According to the Institute of Medicine (2013), “the central goal of its conceptual 
framework is delivering comprehensive, patient-centered, evidence-based, high-quality cancer 
care that is accessible and affordable to the entire U.S. population, regardless of the setting where 
cancer care is provided.” (p. 3) In summary, the six components are engaged patients; an 
adequately staffed, trained, and coordinated workforce; evidence-based cancer care; a learning 
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health care information technology system for cancer; translation of evidence into clinical 
practice, quality measurement, and performance improvement; and accessible, affordable cancer 
care. A full description of each component can be found in the Institute of Medicine (2013) 
report. 
 At the center of this framework is the concept of developing engaged patients. Patient 
engagement is defined as an increase in “a patient’s knowledge, skills, ability, and willingness to 
manage his or her own healthcare.” (p.1; Health Policy Brief: Patient Engagement, 2013). 
Research has found that engaged patients are more likely to receive recommended screening 
tests, report higher quality care, have lower medical costs, less likely to smoke, less likely to be 
obese, and report increases in health enhancing self-management behaviors (Greene & Hibbard, 
2011; Hibbard & Greene, 2013; Hibbard, Mahoney, Stock, & Tusler, 2007). The main 
recommendation to encourage patient engagement is for the cancer care team (e.g. oncologists, 
physician assistants, nurse practitioners, and nursing staff) to provide information, psychosocial 
support, and financial estimates of cancer care to the patients and their families (Institute of 
Medicine, 2013). Further, the report suggests that this communication should be facilitated 
through the use of decision aids and collaboration with patients in the creation of care plans that 
are respectful of the patient’s values and priorities. As such, both the Institute of Medicine 
(2013) and the American Society of Clinical Oncology (2014) have focused their 
recommendations for the development of patient engagement, and subsequently high quality 
cancer care, on improvement in doctor-patient relationships. 
 The doctor-patient relationship is the main mechanism through which patients interact 
with, and understand, their cancer care, and it provides the foundation from which we may be 
able to improve patient engagement. Although both organizations provide recommendations for 
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improving this aspect of cancer care, neither discuss the importance of considering differences in 
preferences for this area according to age, or developmental stage, at diagnosis. Additionally, the 
framework does not discuss the implications of the legal authority of minor patients. Parents are 
the legal medical decision-makers for their children under the age of 18 (or 21 years of age in a 
few states), and they can prevent their adolescent children from playing a role in the decision-
making process (Beh & Pietsch, 2004; Hickey, 2007; Moore & Kirk, 2010; Quinn et al., 2011). 
With adolescence being a time of preparation and transition to adulthood, it is important to 
examine what characteristics of the doctor-patient relationship are associated with better patient 
engagement in this population. 
 There are two main models of the doctor-patient relationship currently discussed in the 
literature – patient-centered care and family-centered care. Both of these frameworks include 
some overlapping constructs, but the primary difference is the increased emphasis placed on the 
role of parents and family members in healthcare decisions within the family-centered model. 
Because the adolescent development period is characterized by major physical, psychosocial, 
and emotional changes across this time (Collins & Steinberg, 2006; Steinberg, Cauffman, 
Woolard, Graham, & Banich, 2009), each of these approaches may be more or less appropriate 
depending on the context and the adolescent’s development. However, without tailored research 
examining these models of doctor-patient relationships within the adolescent oncology setting, 
recommendations for how to interact with these patients to promote patient engagement, and 
subsequently high quality cancer care, remains a challenge. 
 This dissertation aims to partially fill this gap by shedding light on important variations in 
patient engagement and quality of care in adolescent cancer patients. In order to accomplish this 
goal, Chapter 2 will review the relevant literature and describe the study’s conceptual model. 
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Chapter 3 will present the study’s purpose and research questions, and Chapter 4 will describe 
the study’s methodology and data analysis plan. Finally, Chapter 5 will describe the results of the 
study, and Chapter 6 will discuss the results in the context of the current adolescent oncology 
and broader oncology literature, the study limitations, and important future research and clinical 
directions.  
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Chapter 2 
Review of the Literature 
Adolescent Cancer and the Doctor-Patient Relationship 
 Research focusing specifically on the experience of patients diagnosed with cancer 
during adolescence is limited due, in part, to issues with the definition of adolescent (Quinn et 
al., 2011). The limited available research with this population, however, has found that 
adolescents report both positive and negative experiences due to cancer, and these experiences 
are both similar and different from their older and younger counterparts. 
 Adolescent cancer patients report positive and negative outcomes both during treatment 
and in the years following (Bellizzi et al., 2012; Engvall, Cernvall, Larsson, von Essen, & 
Mattsson, 2011; Lehmann et al., 2014; Wesley, Zelikovsky, & Schwartz, 2013). Negative 
outcomes include bodily concerns; problems in social relationships, including later achievement 
in psychosexual milestones and less likelihood of marriage and parenthood; lower life 
satisfaction; fertility concerns; and psychological problems (Dieluweit et al., 2010; Lehmann et 
al., 2014; Seitz et al., 2011). Positive outcomes include a positive view of life, positive view of 
self, and compassion for others (Lehmann et al., 2014). Additionally, a more positive view about 
life years after diagnosis was associated with requesting information soon after diagnosis 
(Engvall et al., 2011). This finding highlights the importance of information provision in the 
adolescent cancer setting.  
 One of the main mechanisms through which patient engagement is developed is the 
provision of quality information concerning cancer, its treatment, and long-term outcomes 
(Institute of Medicine, 2013). In general, adolescents want information, delivered in a 
developmentally appropriate manner, concerning cancer as a disease, available treatments, 
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physical therapy for rehabilitation, complementary and alternative medicine, psychological 
therapy, fertility status, fertility preservation, long-term effects of treatment, and survivorship 
care (Aziz, Oeffinger, Brooks, & Turoff, 2006; Ben Arush, Geva, Ofir, Mashiach, Uziel, & 
Dashkovsky, 2006; Chapple, Salinas, Ziebland, McPerson, & MacFarlane, 2007; Fernandez et 
al., 2009; O’Connor et al., 2013; Stinson et al., 2012). In response to vignettes of different 
oncology visits/experiences, adolescent survivors on and off treatment and their parents preferred 
information to be given to both the patient and the parent simultaneously, but they also reported 
that an 8-year-old patient should receive information at a different time from their parents as 
compared to a 12-year-old patient (Zwaanswijk et al., 2011). In interviews with adolescent 
cancer patients and their parents, Baker et al. (2013) found differences in the priorities of parents 
and adolescents within the clinical trial enrollment discussion, further highlighting the 
importance of both family members and patients in the adolescent oncology setting. 
Most adolescent cancer patients recognize that their personal preference for how much 
information they want is subject to change, most often as they age or move through the cancer 
continuum (Hinds et al., 2005; Zwaanswijk, Tates, van Dulmen, Hoogerbrugge, Kamps, & 
Bensing, 2007). Adolescent cancer patients also discuss the need to be addressed appropriately, 
not like a child or an adult, and they report a lack of resources and services targeted directly to 
their age group (Zwaanswijk et al., 2007; Stinson et al., 2012); they felt as if they were “without 
a home” (p. 282, Stinson et al., 2012) for their cancer experience. Ethnographic interviews with 
staff and patients in an adolescent-focused cancer unit in the United Kingdom concurred with 
these reports because a main benefit of adolescent-focused cancer units was the feeling of shared 
understanding among the people admitted to and working in the adolescent cancer unit (Kelly, 
Pearce, & Mulhall, 2004). 
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 In addition to information provision, the Institute of Medicine (2013) highlights the 
necessity of utilizing shared decision-making practices within the cancer setting. Many 
adolescent cancer patients, both on and off treatment, report wanting to be involved in decision-
making, believe they should make the final decision concerning treatment, and believe they 
should advocate for themselves (Dunsmore & Quine, 1995; Hinds et al., 2005; Stinson et al., 
2012; Zwaanswijk et al., 2007). However, the literature also suggests that there is a discrepancy 
between the role adolescent patients want to play, the role they actually play, and the role parents 
and doctors believe they should play (de Vries, Wit, Engberts, Kaspers, & van Leeuwen, 2010; 
Miller, Baker, Leek, Drotar, & Kodish, 2014; Young et al., 2010). In an observation study of 
informed consent conferences (ICCs) for a clinical trial, Miller et al. (2014) found that only 43% 
of the communication within the ICC involved the adolescent patient, the adolescent stated their 
preference for enrollment in 67% of the ICCs, and the patient was requested to sign the consent 
form in only 49% of the ICCs. 
 Talati, Lang, and Ross (2010) provided vignettes to doctors that described medical 
treatment refusal in minor cancer patients. The vignettes varied in three ways: the diagnosis 
(poor prognosis with treatment vs. good prognosis with treatment), the age of the patient (11 
years old vs. 16 years old), and whether the treatment refusal was made by the patient, the 
parent, or both the patient and the parent. Overall, doctors were more likely to treat in spite of 
refusal in the good prognosis vignette, and were more likely to respect the decision of treatment 
refusal in the poor prognosis vignette. However, across both scenarios, the doctor was more 
likely to accept the decision of the 16-year-old patient as compared to the 11-year-old patient, 
particularly in the poor prognosis scenario when the parent wanted to treat but the patient did 
not. Additionally, over 50% of the doctors said that the 16-year-old patient was the primary 
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decision-maker whereas 98% of the doctors believed the parent was the primary decision-maker 
for the 11-year-old patient. 
 These findings exemplify the importance of examining the doctor-patient relationship 
within this cancer population. The cognitive and psychosocial changes across this developmental 
period provide adolescents with an increased ability to make complex medical decisions, but 
these changes coincide with changes in the still very important parent-child relationship (Benish-
Weisman, Levy, & Knafo, 2013; Grotevant & Cooper, 1998; Kagitcibasi, 2003; Tamis-LeMonda 
et al., 2007). Additionally, as adolescent’s transition into adulthood, and the adult healthcare 
setting, they are expected to begin to make their own, independent healthcare decisions without 
the help of, or less help from, a parent or guardian. Therefore, the doctor-patient relationship 
within the adolescent oncology setting provides an avenue through which patient engagement 
can be developed, and it is important to examine the two most common models for this 
relationship, patient-centered care and family-centered care, and identify which is most 
appropriate, and at what times, during the adolescent development period. A comparison of the 
constructs of these two models of care can be found in Figure 1. Within this figure, constructs 
that are similar across the two models are shaded in a dark gray, constructs that are similar but 
still different from each other are shaded in a light gray, and constructs that are different or 
present in only one model are not shaded. Each model is expanded upon below. 
Patient-Centered Care 
 Patient-centered care has been heavily advocated in the adult medical literature because 
patients want to feel heard, valued, and empowered to play a role in their treatment (Mullins, 
Vandigo, Zheng, & Wicks, 2014). Patient-centered care focuses on understanding the whole 
patient, specifically their values, beliefs, relationships, and environment (Saha, Beach, & Cooper, 
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2008). Across the number of different models of patient-centered care highlighted in a review, 
the common core concepts of patient-centered care include: (1) understanding and respecting the 
patient’s values, beliefs, and preferences; (2) provision of information and preventative 
healthcare; (3) a focus on the doctor-patient relationship, often around sharing power in medical 
decision-making; and (4) consideration of the patient’s environment, such as their relationships 
with family and friends (Saha et al., 2008).  
 Adolescents, too, have opinions about their medical care, and often want to play a role in 
the decision-making process and feel like their values are respected (Coyne, 2006). However, the 
patient-centered model inherently assumes that patients have the legal authority to make medical 
decisions, as well as possess the cognitive and psychosocial skills necessary to do so. 
Adolescents do not always possess all of the skills necessary to make informed treatment 
decisions, especially within the emotionally charged situations that often surround major medical 
decisions (Spear, 2000). This makes it imperative to consider how the preferences of adolescents 
concerning their involvement in their cancer care vary across the adolescent development period. 
 A main focus of the patient-centered care model is its emphasis on individually-tailored 
healthcare, making it applicable to the adolescent chronic illness setting because there is 
variation in the level of involvement desired by adolescent patients (Taylor, Haase-Casanovas, 
Weaver, Kidd, & Garralda, 2010). A systematic review of the adult patient-centered literature 
found an association between the experience of multiple patient-centered care dimensions, such 
as respect for patient preferences, coordination of care, and involvement of family, and patient 
satisfaction and self-management behaviors (Rathert, Wyrwich, & Bore, 2012). Rathert et al. 
(2012) also examined the relationship between individual patient-centered care dimensions and 
various outcomes. The studies varied in outcomes examined, but respect of patient preferences 
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and patient involvement was found to be positively associated with outcomes such as lower 
anxiety, more involvement in medical consultations, and treatment adherence (Rathert et al., 
2012).  
 Adolescents may be able to play a large role in making minor treatment decisions, and 
allowing adolescents the opportunity to ask questions and gain information about their treatment 
provides them an avenue towards participation in major treatment decisions (Coyne, Amory, 
Kiernan, & Gibson, 2014). The provision of information or discussion of preferences is one way 
in which adolescents can be included in the decision-making process, even if the parents are the 
ultimate decision makers. Few studies have analyzed this dynamic, but some preliminary 
evidence suggests that adolescents do not always want to make the final decision, but instead 
want to feel included (Young et al., 2010). The American Academy of Pediatric Committee on 
Bioethics (1998) set out guidelines for decision-making in the pediatric setting, and the 
Committee suggests that children and adolescents should be allowed to participate in decision-
making. Unfortunately, most research on decision-making in the pediatric and adolescent 
medical setting focuses on parents’ role in decision-making, leaving out the adolescent patient’s 
role within the decision-making process (Fiks & Jimenez, 2010; Tates & Meeuwesen, 2001). 
Family-Centered Care 
 With the lack of focus on the importance of both the patient and their family members in 
adolescent healthcare, an alternative model of care that may alleviate these concerns for some 
patients is the family-centered care model. The family-centered care model developed from 
research examining the necessity of parents in pediatric hospital settings in both the United 
States and the United Kingdom (Jolley & Shields, 2009). Even though the presence of parents in 
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the medical setting has been common practice for decades, research still has not identified the 
best way for family members to be involved in the care of their adolescent cancer patient. 
 Frameworks and theoretical considerations have identified five main characteristics of 
family-centered care (Kuo et al., 2012). Kuo et al. (2012) describe these characteristics in detail, 
but in summary, doctor-patient relationships grounded in family-centered care principles will (1) 
provide objective and unbiased information concerning treatment, the diagnosis, and other 
medical decisions; (2) understand the great amount of diversity in culture, language, and care 
preferences among those families being treated for cancer, and respect those differences when 
providing care; (3) be characterized by partnership and collaboration, and treatment decisions are 
approached with shared goals in mind, and all parties make treatment decisions together; (4) 
open all treatment decisions to negotiation as care unfolds and outcomes change, and providers 
and families are flexible and willing to reevaluate treatment decisions if they do not appear to be 
working in the desired way; and (5) remember and consider that all treatment is conducted in the 
context of family and community, and ensuring that treatment decisions are respectful of the 
environment the patient exists in is imperative to quality care. 
 Systematic reviews of family-centered care interventions in pediatric and adolescent 
medical settings have found decreased family conflict, better use of health services, 
improvements in health status, and improvements in family functioning (Kuhlthua et al., 2011; 
McBroom & Enriquez, 2009). Research conducted in Iran with adolescent cancer patients and 
their parents found a significant association between adolescents’ coping strategies and those of 
their parents, highlighting the importance of considering the entire family context when making 
treatment decisions for adolescent cancer patients (Sanjari, Heidari, Shirazi, & Salemi, 2008). 
Lyon, Jacobs, Briggs, Cheng, and Wang (2013) conducted a family-centered advanced care 
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planning intervention with adolescent cancer patients. Overall, adolescents and their families 
who participated in the intervention reported higher levels of congruence on treatment decisions 
and adolescents reported higher levels of understanding concerning end-of-life decisions.  
 Although many of the principles of patient-centered and family-centered care are similar, 
the emphasis they place on the role of the family within the cancer experience marks the major 
difference between these two models of care. As will be described below, developmental 
research supports the use of both of these models of care at varying times throughout the 
adolescent development stage, and in various illness situations. Therefore, research needs to 
examine which of these models of care are associated with increased patient engagement and, in 
turn, higher quality of care. 
Adolescent Development and Transitional Readiness  
Adolescence is a period of development characterized by significant change, and 
important cognitive and social factors unique to this age group may need to be considered within 
the cancer setting. Adolescent development researchers are urging for increased focus on this 
developmental period, suggesting that adolescents should be examined separate from their older 
and younger counterparts (Grisso & Vierling, 1978; Jensen & Chen, 2013; McCabe, 1996). 
These recommendations complement the recommendation of the NCI and LiveStrong progress 
review group to consider narrower distinct groups of patients within the AYA cancer population 
(NCI, 2006). 
 Over the course of adolescence, individuals experience a number of physical, cognitive, 
and psychosocial changes (McNeely & Blanchard, 2009). These changes will impact 
adolescents’ daily lives, their healthcare, and their ability to take on adult responsibilities when 
they reach 18 years of age. This transition from the dependence of childhood to the independence 
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of adulthood occurs within the education, financial, and vocational domains of life for most 
individuals, including cancer patients. However, adolescent cancer patients also need to 
transition from pediatric to adult healthcare settings, and this transition marks an important 
change for some of these patients – responsibility for their own healthcare. Although parents 
may remain involved in healthcare during young adulthood, adolescents still need to prepare for 
independent medical decision-making and care management. As such, doctors within the 
oncology setting need to consider all of the physical, cognitive, and psychosocial changes 
common during this period of development when determining the best ways to provide care. 
 Adolescents begin to improve their reasoning skills and information processing abilities, 
and start to gain expertise in areas of interest (Collins & Steinberg, 2006). Abstract and 
hypothetical thinking improves throughout early adolescence and into middle adolescence, and 
by late adolescence individuals are able to utilize foresight, plan ahead, and set goals and achieve 
them (Collins & Steinberg, 2006; McNeely & Blanchard, 2009; Mello et al., 2009; Piaget 
1972/2008). Neuroscience research has found that the area of the brain responsible for executive 
functioning, the prefrontal cortex, develops gradually across adolescence and into young 
adulthood (Bonnie & Scott, 2013). Specifically, changes in the brain structure account for 
increases in information processing speed, the ability to do physical and mental work, the ability 
to plan ahead, and the ability to consider multiple sources of information in decision-making 
(Keating, 2012; McNeely & Blanchard, 2009; Overton, 1990; Spear, 2000; Steinberg, 2009). 
Therefore, although adolescent brain function has improved from early and middle childhood, 
there are still some important functions that are developing as they reach the late stages of 
adolescence and begin to transition into young adulthood. This makes it difficult for adolescents 
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to participate in some aspects of medical decision-making without the help of a parent or 
healthcare provider. 
 Psychosocial development represents important changes in emotion regulation and social 
relationships that occur during the adolescent period. Increases in dopamine during early 
adolescence make individuals prone to risk-taking or sensation-seeking (Chambers, Taylor, & 
Potenza, 2003), and increases in cortical connections in late adolescence allow higher levels of 
emotion regulation (Eluvanthigal, Hasan, Kramer, Fletcher, & Ewing-Cobbs, 2007; Steinberg, 
2009). The increase in these connections is what allows adults to make logical and rational 
decisions in the face of emotionally-charged situations, like the diagnosis of a life-threatening 
illness, something that may be difficult for adolescents to accomplish on their own (Turner-
Henson, 2005). 
 These cognitive and psychosocial changes mark important considerations when analyzing 
the readiness of an adolescent patient to transfer from pediatric to adult healthcare, an important 
transition for any individual with special healthcare needs. Adolescents with special healthcare 
needs that successfully transition to adult healthcare report satisfaction with the increase in 
control, improvements in health-related quality of life, and improvement in health status 
(Holmes-Walker, Llewellyn, & Farrell, 2007; McDonagh, Southwood, & Shaw, 2007; Tuchman, 
Slap, & Britto, 2008). The American Academy of Pediatrics (AAP), the American Academy of 
Family Physicians (AAFP), the American College of Physicians-American Society of Internal 
Medicine (ACP-ASIM), and the Transitions Clinical Report Authoring Group (TCRAG; 2011) 
created an algorithm to guide the transition process for adolescent patients with special 
healthcare needs. Within these guidelines, the authors highlighted the importance of regular (at 
least yearly) assessments of an adolescent’s ability to self-manage their healthcare, ability to live 
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independently, and identify appropriate educational or vocational training (AAP et al., 2011). 
These continual assessments across time allow for tracking of the developmental changes 
common in this stage of development, altering the adolescent’s medical involvement 
accordingly, and stepping away from assuming the development of certain skills based on age 
ranges. However, research conducted on transition medicine following the publication of these 
guidelines have found mixed results (Bloom et al., 2012). Although researchers and clinicians 
agree that transition medicine should be tailored to each individual patient, continue to evaluate 
the adolescent’s self-management abilities, and that the process should start early (Al-Yateem, 
2013), large scale surveys of youth with special healthcare needs found that between only 21.6 to 
40.0 percent report meeting these transitional goals (McManus et al., 2013; Oswald et al., 2013; 
Sawicki et al., 2011).  
 With patient engagement being the center of the Institute of Medicine’s (2013) 
framework for high quality cancer care, it is imperative to consider how to improve engagement 
in the adolescent cancer population. However, the vast amount of changes that occur during the 
adolescent development period make it impractical to suggest that only one element of the 
doctor-patient relationship is satisfactory to improve patient engagement. Therefore, the doctor-
patient relationship, the patient’s age, and their developmental status all need to be considered 
when examining patient engagement and quality of care in the adolescent oncology setting.  
Study Conceptual Model 
 Highlighting the importance of examining several potentially relevant factors associated 
with patient engagement and quality of care in the adolescent oncology setting, a diagram of this 
study’s conceptual model was developed and can be found in Appendix B. As can be seen in the 
model, the main relationship of interest is the association between patient engagement and 
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quality of care in adolescent oncology. In addition to support for this relationship in the empirical 
literature, the Institute of Medicine (2013) framework highlights this relationship as the center of 
quality of care improvement. However, the literature on adolescents and adolescent cancer 
patients more specifically suggest that this relationship does not occur in isolation from other 
important factors, including the model of care utilized in the doctor-patient relationship and the 
patient’s age and developmental status. Therefore, as can be seen in the diagram, this study will 
also examine the role patient-centered care and family-centered care play in the association 
between patient engagement and quality of care. Finally, these interactions occur within the 
context of the patient’s age and developmental status. As these two variables are constantly 
changing, it is important to consider how they relate to all of the variables examined in this 
study. 
The larger goal within the field is to provide high quality cancer care to all cancer 
patients, and research suggests that engaged patients perceive higher quality care and experience 
better health outcomes (Greene & Hibbard, 2011; Hibbard & Greene, 2013; Hibbard et al., 
2007). However, this research has not considered developmental variability in the ability and 
desire to be engaged in healthcare. In order to provide high quality care to adolescents, we need 
to first understand what patient engagement looks like for them, how it’s associated with their 
perception of quality of care, and the role doctors and parents may play in this relationship. 
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Chapter 3 
Present Study 
 This study examined the relationship between patient engagement and quality of care in 
the adolescent oncology setting. Additionally, this study explored how the relationship between 
patient engagement and quality of care is moderated by patient-centered care, family-centered 
care, age, and developmental stage. The Institute of Medicine (2013) places the engaged patient 
at the center of their high quality cancer care framework, arguing that supporting patient 
engagement within the cancer setting is the highest priority for the improvement of cancer care 
in the United States. Therefore, it is important to consider what specific models of care (i.e. 
patient-centered care and/or family-centered care) utilized during cancer care in adolescence are 
associated with higher levels of patient engagement and quality of care. 
 Currently, there is little research that explicitly looks at the experience of the doctor-
patient relationship for adolescent cancer patients (Siembida & Bellizzi, 2015). Additionally, the 
small, mixed-age samples commonly used in research within this population, and lack of 
agreement on a definition of “adolescent” makes it difficult to examine whether patient-centered 
care, family-centered care, or the use of both models of care at different times across the 
adolescent development period is more appropriate within the adolescent oncology setting 
(Siembida & Bellizzi, 2015). Finally, decisions made by doctors and family members are often 
driven primarily by age, but developmental research suggests there is great individual variation 
in the timing of developmental milestones across this period of the lifespan, making age as a 
marker for developmental skills potentially inappropriate (Berger, 2005; McNeely & Blanchard, 
2009). 
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 Due to these limitations, and a focus in the cancer literature on improvement in quality of 
care, the first aim of this study was to examine patient engagement and quality of care: 
RQ1: What is the relationship between patient engagement and quality of care in the 
adolescent oncology setting? 
Hypothesis 1: Adolescents with higher levels of patient engagement will report 
higher quality of care. 
Since little research has focused on the doctor-patient relationship in adolescent oncology, the 
second aim of the current study was to examine the frequency of the two most common models 
of care, patient-centered and family-centered care: 
RQ2: What is the frequency of patient-centered care and family-centered care within the 
adolescent oncology setting? 
Hypothesis 2: Family-centered care will be experienced more frequently by 
adolescent cancer patients. 
Research on both patient-centered and family-centered care have found them to be good models 
of care associated with a number of positive patient outcomes, however, research has not 
considered how the appropriateness of these models of care for each individual patient may vary 
as a function of patient age and developmental stage: 
RQ3: How does the frequency of patient-centered care and family-centered care vary 
according to the adolescent patient’s age or developmental stage (measured by cognitive 
autonomy and transitional readiness)? 
Hypothesis 3a: The experience of patient-centered care will increase as 
adolescents get older. 
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Hypothesis 3b: The experience of family-centered care will decrease as 
adolescents get older. 
Hypothesis 3c: The experience of patient-centered care will increase as 
adolescents’ developmental stage (measured by cognitive autonomy and 
transitional readiness) increases. 
Hypothesis 3d: The experience of family-centered care will decrease as 
adolescents’ developmental stage (measured by cognitive autonomy and 
transitional readiness) increases. 
The limited research available on adolescent cancer patients and the doctor-patient relationship 
suggests that the experience of patient-centered care, family-centered care, a patient’s age, and a 
patient’s developmental stage may all play a role in an individual’s engagement in their 
healthcare. As such, the final aim of this study was to explore how the relationship between 
patient engagement and quality of care may be moderated by these three variables: 
RQ4: How is the relationship between patient engagement and quality of care moderated 
by patient-centered care, family-centered care, age, and developmental stage (measured 
by cognitive autonomy and transitional readiness)? 
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Chapter 4 
Methods 
Participants 
 Inclusion criteria for the current study were: most recent cancer diagnosis (either initial 
diagnosis or recurrence) between the ages of 10 and 20, being at least 3 months from most recent 
diagnosis, having received active treatment including a form of treatment other than surgery 
(individuals who had a tumor removed but no other forms of treatment were not considered 
eligible), and no more than 2 years off active treatment. There was no cap placed on the 
maximum age participants could be at the time of recruitment as long as they fit all of the 
inclusion criteria. However, the oldest participant in the current study was 21 years of age at the 
time of the survey.  
The age range of 10 to 20 years of age at diagnosis was chosen in order to account for the 
developmental changes that occur across this time period, the legal implications of minor 
patients, and cross-cultural variations in the definition of adolescent patients (JAYAO, 2011). 
Additionally, patients’ most recent cancer diagnosis, either their initial diagnosis or their most 
recent recurrence, was used to determine eligibility for this study. Therefore, patients could have 
been diagnosed with cancer prior to age 10, but have experienced a recurrence at age 15 and 
qualified for participation. Patients were required to be at least 3 months from their most recent 
diagnosis (either initial diagnosis or recurrence) to allow them to process their diagnosis. By 
utilizing this inclusion criterion, the prevention and screening stages of the cancer care 
continuum were not examined. Because these conversations are often conducted in the general 
practice or pediatric setting, and do not typically include the oncology medical team, these stages 
were not the focus of the current study.  The current project was interested in examining 
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communication within the oncology setting. Finally, the longer-term survivorship stage of the 
cancer care continuum was not examined because participants would have had to retrospectively 
consider their experiences during cancer treatment, and since this could have occurred many 
years ago, their responses could be prone to bias.  
 Potential participants were excluded from participation if they did not meet all of the 
above inclusion criteria, or fit into one of the exclusion criteria categories. Specifically, potential 
participants were excluded if they: could not read or speak English, were diagnosed with a 
developmental disorder, or they were diagnosed with a physical disability that would prevent 
them from completing the survey (i.e. blindness).  
 To determine eligibility for the study, patient charts were screened for inclusion criteria 
by the principal investigator and clinical research and nursing staff at the two hospitals. A total 
of 97 participants fit the inclusion criteria. Of the 97 qualified participants, 86 were approached 
about the current study. The most common reasons for not approaching qualified participants 
included appointment cancellations or research staff missing the patient while at clinic. Of those 
approached, 82 individuals agreed to participate, and 81 participants completed the survey. 
Therefore, this study had a participation rate of 94.2%. Most participants did not give a reason 
for refusal, but those that did usually indicated they did not have enough time to complete the 
survey. Following data collection, one additional participant was eliminated due to missing data. 
Overall, a sample of 80 individuals was examined for this study. A flowchart describing the 
recruitment process of the current study can be found in Figure 2. 
Participant Recruitment 
 Participant recruitment occurred from November 2, 2015 to April 1, 2016 at two 
metropolitan medical centers – Smilow Cancer Hospital at Yale-New Haven and Connecticut 
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Children’s Medical Center (CCMC). Institutional Review Board (IRB) approval was received 
from CCMC, and honored by the Yale Medical School IRB and the University of Connecticut 
IRB. Located in southern Connecticut, Smilow Cancer Hospital has a pediatric 
hematology/oncology program that serves up to 100 new patients every year. The pediatric 
hematology/oncology program at Smilow Cancer Hospital serves infant, children, and young 
adult patients who are receiving treatment for cancer. Over the course of study recruitment, 27 
patients fit the inclusion criteria for this study, and 25 were approached. Of the 25 individuals 
approached, 24 agreed to participate in the project, leading to a participation rate of 96.0% at 
Smilow Cancer Hospital.  
 As a whole, CCMC serves children and adolescents that require medical care, and it is 
one of only two free-standing medical centers focused on providing care to pediatric populations 
in New England. The CCMC hematology/oncology department has a specific program of care 
dedicated to the treatment and experience of adolescents and young adults diagnosed with 
cancer, and an estimated 150 patients served in the clinic meet the inclusion criteria of the study. 
Over the course of recruitment, 70 patients fit the inclusion criteria for this study, and 61 were 
approached. Of the 61 approached, 57 agreed to participate in this study, leading to a response 
rate of 93.4% at CCMC. 
 The recruitment strategies at each site were similar, but varied slightly. At Smilow 
Cancer Hospital, a nurse practitioner who works with adolescent cancer patients was the main 
point of contact for recruitment. She screened through the daily appointments on the days she 
was present in clinic, and the principal investigator came into the outpatient clinic on any day a 
qualified participant had an appointment. Once at the clinic, the principal investigator also 
contacted a physician assistant working on the pediatric oncology inpatient floor and asked if any 
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qualified patients were currently admitted. For those potential participants with outpatient 
appointments, the nurse practitioner approached them during their clinic appointment and 
introduced them to the study or gave them the study flyer. The study flyer can be found in 
Appendix C. If the participant expressed interest, the principal investigator approached the 
participant, gave more details, consented the participant, and administered the survey on a tablet. 
Participants who were given the flyer also had the option of texting “adolescent survey” to the 
principal investigator to indicate interest in the study. For potential participants recruited on the 
inpatient floor, the physician assistant and the principal investigator approached patients in their 
hospital rooms and the physician assistant introduced the principal investigator. The principal 
investigator then gave more background about the study, consented interested patients, and 
administered the survey on a tablet.  
 Participant recruitment at CCMC was conducted in-person at the CCMC 
hematology/oncology clinic. Prior to the start of recruitment, the principal investigator attended a 
hematology/oncology department staff meeting to introduce herself and the project. Recruitment 
occurred on all clinic days that had qualifying patients scheduled. At the beginning of each week, 
the principal investigator screened through the clinic’s weekly appointments and determined who 
was eligible for the study. Throughout the week, either the principal investigator or a clinical 
research associate employed by CCMC would recruit participants. Prior to approaching qualified 
patients, the principal investigator or clinical research associate asked nursing staff or doctors if 
that day was a good time to approach the patient concerning the study, and asked at what time 
during their appointment would be the best moment for approach. After identifying the best 
moment of approach, participants were approached about the study. They were given a brief 
introduction to the study, consented if interested, and administered the survey on an iPad. 
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 Recruitment was conducted in-person at both Smilow Cancer Hospital and CCMC, and 
as such, a member of the research team was always present during the survey to answer any 
questions the participant may have. At the start of the survey, participants were also told that 
they were able to ask their parent/guardian any questions they may have as well. All participants 
received a $20 Amazon gift card for participating in the study. 
Data Collection 
 Data for this study was collected using an online survey developed using Qualtrics. The 
survey was anonymous; IP addresses were not collected, and email addresses were not linked to 
individual survey responses. The first page of the survey was an informational page introducing 
the study, the study’s purpose, why the person was directed to the study, and provided 
information on the compensation they would receive for completing the survey. This page also 
included contact information for the study research team. A copy of the online survey 
introduction can be found in Appendix D. 
 Parents were then directed to the consent page where they read and agreed to their child’s 
participation in the study. Individuals could not continue forward in the survey without agreeing 
to the consent page. The adolescent participants were then directed to the assent page where they 
read and agreed to participate in the survey. Participants could not begin the survey without 
agreeing to the assent page. After consent and assent were obtained, participants were directed to 
the start of the online survey. Participants moved through the survey one screen at a time, and 
participants were provided the option to skip any question they were not comfortable answering. 
The majority of participants completed the survey in 10 to 15 minutes. 
Survey Pre-Testing 
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 Because of the differences in reading comprehension and cognitive development among 
the targeted population, the survey was pre-tested with a small focus group of adolescents. The 
purpose of the pre-testing focus group was to elucidate whether or not the survey was able to be 
used with participants in the targeted age range for this study (10-20 years of age at diagnosis). 
We were specifically interested in making sure that the questions and response items were 
understandable, and that most participants were able to complete the survey in about 15-20 
minutes. All of the measures utilized in this study were previously validated with high school 
and older populations, so recruitment efforts were focused on participants in the younger range 
of the target age group. We used a targeted recruitment strategy for the pre-testing focus group, 
and identified a staff member at a local K-8 school who agreed to work with the research team 
on identifying potential participants for the pre-testing focus group.  
 The staff member was instructed to focus on individuals between the ages of 10 and 13, 
regardless of their medical history. When a potential participant was identified, the staff member 
contacted the parent and/or guardian and briefly discussed the study, the purpose of pre-testing, 
the length of the time commitment for their child (about 30 minutes), and compensation for 
participation. When the parent agreed to have their child participate, the principal investigator 
met with the participant, explained the pre-testing procedures, and begin the pre-testing process. 
Consent and assent was received through the online survey, and then participants took the online 
survey without interruption. This first step monitored how long it took individuals to complete 
the survey. Once the participant finished taking the survey, the principal investigator conducted 
cognitive interview testing with the participant, and then gave them their $20 Amazon gift card. 
The survey was modified slightly to change terms like “oncologist” or “cancer care team” to 
more general phrases like “your doctor” or “your medical providers.” Questions related 
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specifically to a cancer diagnosis (i.e. ‘what was your cancer diagnosis’ or ‘what types of 
treatment have you received for your cancer’) were eliminated, and one question asking if they 
had been diagnosed with any chronic illnesses was added. 
 The cognitive testing was conducted by the principal investigator under the supervision 
of her major advisor, Dr. Bellizzi, who has previous experience with these procedures. A 
retrospective verbal probing technique modified for use in childhood populations was used to 
determine the developmental validity of the survey (Willis & Research Triangle Institute, 1994; 
Woolley, Bowen, & Bowen, 2004). Following completion of the survey, the principal 
investigator went back through the survey with the participant and asked the following questions, 
as appropriate: (1) asked the child to read the question aloud, (2) asked the child to repeat the 
question in their own words, (3) asked the child to pick the best answer to the questions, and (4) 
asked the child to explain why they chose their answer (Woolley et al., 2004). Following 
completion of each cognitive interview, the principal investigator summarized each child’s 
responses along with her own observations on a question-by-question basis, and these notes were 
then aggregated across all the pre-test participants (Willis & Research Triangle Institute, 1994).  
 A total of 4 adolescents were recruited as part of the pre-testing focus group. The pre-
testing participants ranged in age from 10 to 17 and there were 2 boys and 2 girls. Two of the 
pre-testing participants had been previously diagnosed with a chronic illness, including 
ADHD/ADD and diabetes. It took the participants an average of 11 minutes to complete the 
survey. The pre-testing focus group had the most trouble on questions concerning transitional 
readiness, and found the response options for cognitive autonomy the most difficult to 
understand. Demographic details and survey completion time about each pre-testing participant 
can be found in Table 1, and the aggregated pre-testing notes and changes made to the survey in 
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response to the focus group responses can be found in Appendix E. These aggregated pre-testing 
notes were reviewed by the principal investigator and Dr. Bellizzi, and they determined the 
appropriate changes to be made to the survey. The final version of the survey used in the current 
study can be found in Appendix F. The remaining discussion of the study measures represents 
the final, modified version of each measure based on the pre-testing process. 
Measures 
 Demographic information. The online survey included questions that asked about 
demographic characteristics of the participants. The demographic characteristics included were 
age, gender, education, racial/ethnic group, treatment location, cancer diagnosis, age at 
diagnosis, time since diagnosis, time since end of treatment, type of treatment, and recurrence 
history. These demographic characteristics were assessed by questions listed at the start of the 
survey, and participants were instructed to ask their parent or guardian for help if they were 
unsure of the answer to any of the questions. 
 Patient engagement. A modified version of the Health Self-Efficacy subscale of the 
Youth Engagement with Health Services (YEHS!) survey was used to evaluate patient 
engagement (Sebastian, Ramos, Stumbo, McGrath, & Fairbrother, 2014). The YEHS! survey 
was developed and validated for use with healthy adolescent populations. Because it was 
originally developed for use with healthy populations, individual items were modified or 
eliminated to focus explicitly on care received within the oncology setting. The YEHS! survey 
included five items, and participants were asked to respond to each item using a 4-point Likert 
response scale with 1 = Strongly disagree, 2 = Somewhat disagree, 3 = Somewhat agree, and 4 = 
Strongly agree. Items on this scale included: “I have a safe and trusting relationship with at least 
one member of your cancer care team” and “I will tell my oncologist my concerns, even if they 
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do not ask.” The five items were summed to create a patient engagement score, and scores could 
range from 5 to 20. Higher scores represent more patient engagement. Internal consistency for 
the present sample was fair, Cronbach’s α = .76.  
 Models of care. Patient-centered and family-centered care were measured using a 
modified, shortened version of the Give Youth a Voice (GYV) questionnaire (Klassen et al., 
2013) and the Measure of Processes of Care (MPOC-20) scale (Klassen et al., 2008). In order to 
decrease participant burden and eliminate overlapping questions, items most relevant to the 
theoretical constructs of patient-centered care and family-centered care discussed in the 
introduction of this proposal were chosen from each measure to create a fourteen item scale with 
eight questions measuring patient-centered care and six questions measuring family-centered 
care. Additionally, the questions taken from the MPOC-20 scale were modified to extract the 
adolescent’s perspective. The original scale was intended for use with parents of pediatric cancer 
patients. 
The instructions asked participants to think about the doctors and nurses who helped 
during their cancer treatment and identify how often each item happened or did not happen. 
Participants were asked to respond to each item using a 4-point Likert scale with the following 
labels: 1 = never, 2 = sometimes, 3 = most of the time, and 4 = all the time. Participants were 
also able to select ‘does not apply to me’ as a response. An example of an item from each scale 
include: “allow you to answer questions” (patient-centered care) and “show they care about you 
and your family” (family-centered care). The scores were summed across all items in each 
subscale (‘does not apply to me’ responses were given a score of 0 for these calculations). 
Patient-centered care scores could range from 0 to 32 with higher scores indicating more patient-
centered care received. Family-centered care scores could range from 0 to 24 with higher scores 
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indicating the receipt of more family-centered care. Internal consistency for the present sample 
on patient-centered care was good, Cronbach’s α = .84. Internal consistency for the present 
sample on family-centered care was poor, Cronbach’s α = .68. 
 Quality of care. Perceived quality of care, or experience of care, was measured using the 
self-report Experience of Care Subscale from Sebastian et al.’s (2014) Youth Engagement with 
Health Services (YEHS!) survey. This subscale was originally developed as part of Hays et al.’s 
(1999) Consumer Assessment of Health Plans Study (CAHPS), but the current study utilized the 
question and response format from Sebastian et al.’s (2014) survey because it was tested and 
validated with an adolescent sample. This scale included five questions that measured 
adolescent’s perceptions of the care they received from their health care providers. Questions 
were modified slightly to focus them specifically on the oncology setting. Participants responded 
using a 4 point Likert scale with responses ranging from 1 = Strongly disagree to 4 = Strongly 
agree. Items from this scale included questions such as “During cancer treatment, did your 
oncologist or other members of your cancer care team listen carefully to you” and “During 
cancer treatment, did your oncologist or other members of your cancer care team explain things 
in a way that you could understand?” The scores were summed across the five items, and scores 
could range from 5 to 20. Higher scores indicated the perception of higher quality of care. 
Internal consistency for the present sample was poor, Cronbach’s α = .37. 
 Due to the poor reliability for the quality of care measure, exploratory analyses were 
conducted to determine which item(s), if any, was causing reliability concerns. By looking at 
item-level specific results, it was determined that the item “Did you have a hard time speaking 
with or understanding your care team because you spoke different languages” was causing the 
low reliability in the present sample. This was unsurprising because the majority of the 
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participants in the current study were monolingual in English, and their doctors also spoke 
English. A number of participants expressed confusion on how to answer this item as they did 
not believe it applied to them. Due to the results of both the analyses and the anecdotal evidence 
of the primary investigator’s experience during data collection, this item was removed from 
analyses. Therefore, perceived quality of care was measured using the modified four-item scale 
with scores ranging from 4 to 16 and higher scores indicating a perception of higher quality of 
care. Internal consistency for the modified scale in the present sample was satisfactory, 
Cronbach’s α = .72. 
 Developmental stage. In order to determine if the use of patient-centered care or family-
centered care varies according to development, two measures of developmental milestones were 
included. Development includes a number of important changes across the adolescent period, but 
for the sake of participant burden, only two areas of development were measured in this study – 
cognitive development and transitional readiness. Both of these developmental areas are 
particularly important when examining decision-making and engagement in a health care setting. 
Cognitive development was measured using the Cognitive Autonomy and Self-Evaluation 
(CASE) Inventory (Beckert, 2007). The final version of the inventory was tested in a sample of 
adolescents ranging from 7th grade to college students under the age of 20 and found that the 
measure was able to discern cognitive differences among this diverse age group (Beckert, 2007). 
The full inventory includes 27 items grouped into five subscales: evaluative thinking (8 items), 
voicing opinions (5 items), decision making (6 items), self-assessing (3 items), and comparative 
validation (5 items). For the current study, only those questions from the decision making and 
evaluative thinking subscales were utilized, and a total of 14 questions were used to measure 
cognitive development. Participants were asked to score each item on a 4-point response scale: 
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never, sometimes, often, and always. Items from each subscale are as follows: “I think about the 
consequences of my decisions” (evaluative thinking) and “There are consequences to my 
decisions” (decision making). Scores were summed across the 14 items, and scores could range 
from 14 to 56 with higher scores indicating higher cognitive autonomy. Internal consistency for 
the CASE Inventory in the current sample was good, Cronbach’s α = .85.  
 To measure transitional readiness, a modified version of the Transition Readiness 
Assessment Questionnaire (TRAQ) was used (Sawicki et al., 2011). The TRAQ was developed 
to assess the readiness of young adults with special health care needs to transition to adult 
healthcare services and independent living. In order to modify this measure to be used with 
adolescent cancer patients, where appropriate, individual items were altered or eliminated to 
focus explicitly on care within the adolescent oncology setting. This measure included 8 items, 
and participants were asked to respond to each item using a 4-point Likert scale with 1 = never, 2 
= sometimes, 3 = often, and 4 = always. Participants were also able to select “My 
parent/guardian does this” for all 8 questions, and “Does not apply to me” for some of the 
questions. Example items included "Do you fill out the medical history form, including a list of 
your allergies” and “Do you apply for a job or college when necessary?” Scores for each item 
were dichotomized with participants indicating they ‘never’ did the item, their ‘parent/guardian’ 
does the item, or it ‘does not apply’ to them given a score of 0, and those who indicated doing 
the item at any level given a score of 1. The dichotomized variables were then summed across all 
8 items, and scores could range from 0 to 8. Higher scores indicated participant’s increased 
readiness to transition to independent living. 
Data Analysis 
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 Power analysis. In order to determine the necessary sample needed to test the hypotheses 
of the current study, a power analysis was conducted using G*Power 3, a statistical power 
analysis program (Faul, Erdfelder, Lang, & Buchner, 2007). In order to determine the sample 
size needed for this study, two separate power analyses were run; the first for the multiple linear 
regression conducted to analyze the first research question, and the second for the multiple linear 
regression conducted to analyze the fourth research question. For the first power analysis, a 
linear multiple regression: fixed model, R2 deviation from zero was selected as the type of test, 
and an effect size of 0.15 (a moderate effect) was chosen because previous research with the 
YEHS! scale (Sebastian et al., 2014) found results with moderate to large effect sizes. The alpha 
level was set at .05, the power was set to .80, and a total of 7 predictors were tested within the 
final model. With these parameters, G*Power 3 calculated that a total sample of 103 participants 
was necessary for these analyses. With a final sample of 80 patients, this necessary sample size 
was not met. 
 An additional goal of the current study was to explore moderation analyses. Because this 
was an exploratory aim, a sample size necessary for these analyses was not targeted, however, a 
second power analysis was conducted to determine the necessary sample size needed to run the 
moderation analyses with satisfactory power. In order to determine this, a linear multiple 
regression: fixed model, R2 deviation from zero was selected as the type of test, and an effect 
size of 0.15 was chosen, as described above. The alpha level was set at .05, the power was set at 
.80, and the number of predictors was set at 11 in order to include the need for interaction terms. 
With these parameters, G*Power 3 calculated that a total of 123 participants was necessary to 
run moderation analyses with satisfactory power. Because the research question specific to the 
moderation analyses was an exploratory question, the final proposed sample size for this project 
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was 103 participants. The final sample size analyzed in this study was 80 participants, and as 
such, the moderation analyses conducted in this study were underpowered; however, bootstrap 
samples (as described later in the data analysis section) were utilized to combat this concern. 
Additionally, due to the scant research conducted with this population and the exploratory aim of 
this question, these analyses still provide useful information.  
 Data management. Data management and cleaning was conducted during recruitment 
and following recruitment completion. At the end of each month of recruitment, data was 
downloaded from the Qualtrics website and cleaned. The data cleaning process included 
recoding variables according to the codebook, preparing the data to be uploaded into SPSS, and 
identifying missing data.  
 Managing missing data is an important step in the analysis process. Therefore, this study 
took a conservative approach to missing data. Participants that were missing more than 25% of 
their data were eliminated from all further analyses. Next, individual items were analyzed for 
missing data. If an individual item was missing more than 10% of its data, the item was removed 
from the dataset. Since the variables of interest in this study are created from a combination of 
items, missing data was also examined at the variable level. To accomplish this, a number of 
things were assessed. First, if any items were deleted due to missing data, each variable was 
examined to make sure enough items still remained to lead to reliable analysis of the variable. 
Each variable needed to have at least 4 items. Next, if participants were missing a score on just 
one or two items from the measure, scores on the composite variable were calculated by giving 
the missing items a score of zero. Finally, if across participants more than 10% of the data is 
missing, than the variable will be eliminated from analysis. 
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Descriptive statistics and correlations. Before conducting analysis for each of the 
research questions and hypotheses, descriptive statistics and correlations were examined. 
Descriptive statistics that were calculated included means and standard deviations for continuous 
variables, and Ns and percentages for categorical variables. Because the main analytic approach 
in the current study was multiple linear regression, regression diagnostics were analyzed to 
determine if any assumptions of the regression framework were violated. Specifically, 
multicollinearity, Cook’s Distance, Mahalanobis distance, homoscedasticity, and distribution of 
residuals were all analyzed. Both correlations and the variance inflation factor (VIF) were used 
to assess multicollinearity between the variables of interest in the current study. A cutoff of 2.50 
on the VIF was used to determine multicollinearity concerns; if a variable had a VIF above 2.50, 
then it was examined further for multicollinearity issues.  
RQ1 and hypothesis 1. The first research question and accompanying hypothesis aimed 
to examine the relationship between patient engagement and perceived quality of care. In order 
to answer this question, a two-step analytical process was used. First, a Pearson correlation 
coefficient was calculated between patient engagement and perceived quality of care to 
determine the presence of a significant bivariate relationship. Next, a multiple linear regression 
model with two steps was developed. The first step included any demographic or illness-related 
variables found to be significantly associated with perceived quality of care. These significant 
relationships were determined using Pearson correlations, t-tests, and ANOVAs, where 
appropriate. The second step added patient engagement to the model to determine if patient 
engagement was a significant, unique predictor of perceived quality of care over and above the 
control variables. 
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 RQ2 and hypotheses 2. The second research question and its accompanying hypothesis 
examined the frequency of patient-centered care and family-centered care in the adolescent 
oncology setting. To answer this question, frequencies and descriptive statistics were calculated. 
Specifically, the participants’ average score for the patient-centered care measure and the family-
centered care measure were analyzed, and the percentage of participants who reported 
experiencing each model of care was analyzed. Results of this analysis indicated if participants 
experienced one model of care more frequently, less frequently, or at a similar frequency as 
compared to the other model of care. 
 RQ3 and hypotheses 3a, 3b, 3c, 3d. The third research question and its accompanying 
hypotheses examined if the frequency of patient-centered and family-centered care varied based 
on the patient’s age or developmental stage. To answer this question a two-step analysis process 
was conducted. First, Pearson correlation coefficients were calculated for the following 
associations: patient-centered care and patient age; family-centered care and patient age; patient-
centered care and cognitive development; family-centered care and cognitive development; 
patient-centered care and transitional readiness; family-centered care and transitional readiness; 
patient-centered care and patient engagement; family-centered care and patient engagement; 
cognitive development and patient engagement; and transitional readiness and patient 
engagement. If significant correlations between the models of care, patient age, the 
developmental measures, and patient engagement were found, additional analyses were 
conducted to further explore how the relationship between model of care and patient engagement 
varies as a function of age and/or developmental stage.  A linear regression, moderation 
framework using the PROCESS macro in SPSS was utilized to examine the relationship between 
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patient-centered care and family-centered care and patient engagement as a function of age and 
developmental stage.  
If significant correlations were found between patient-centered care and patient age, 
cognitive development, transitional readiness, and/or patient engagement, the first model 
examined patient-centered care as the independent variable, patient engagement as the outcome 
variable, and age, cognitive development and/or transitional readiness as the moderator(s). For 
this analysis, Model 2 was selected, and 2000 bootstrap samples were calculated. All 95% 
confidence intervals were bias corrected, and patient-centered care, patient age, cognitive 
development, and/or transitional readiness were mean-centered. Heteroscedasticity-consistent 
standard errors were calculated to protect against any violation of the homoscedasticity 
assumption. Mean centering the predictor and moderating variables allows for the examination 
of the effect of one variable on the outcome at the mean level of the other variables in the model.  
The second model tested the moderating role of patient age, cognitive development, 
and/or transitional readiness on the relationship between family-centered care and patient 
engagement. For this analysis, Model 2 was selected, and 2000 bootstrap samples were 
calculated. All 95% confidence intervals were bias corrected, and family-centered care, patient 
age, cognitive development, and/or transitional readiness were mean-centered. 
Heteroscedasticity-consistent standard errors were calculated to protect against any violation of 
the homoscedasticity assumption. Mean centering the predictor and moderating variables allows 
for the examination of the effect of one variable on the outcome at the mean level of the other 
variables in the model. 
These models provide information regarding the unique contribution of each model of 
care on the variance of patient engagement, and will test the interactions between each model of 
 38 
 
care and age and development on the variance of patient engagement. A significant interaction 
implies that one model of care is significantly associated with patient engagement at specific 
ages and/or developmental stage in adolescent oncology patients.  
The main limitation of the PROCESS macro for analyzing moderation is the inability to 
examine more than one independent variable in the same model. Therefore, if no significant 
interactions are present, both models of care and developmental measures will be included in a 
multiple linear regression framework to determine the relationship between these independent 
variables and patient engagement when examined together.  
 RQ4. The fourth research question aimed to explore if the relationship between patient 
engagement and perceived quality of care was moderated by patient-centered care, family-
centered care, age, and/or developmental stage. To answer this research question, the PROCESS 
macro was utilized to run three separate moderation analyses.  
The first model tested the moderating roles of patient-centered care and family-centered 
care on the relationship between patient engagement and perceived quality of care. Before 
creating the model, bivariate correlations and ANOVAs were conducted with demographic and 
illness-related variables and perceived quality of care. If any significant relationships were 
present, the demographic or illness-related variables were included as covariates. The PROCESS 
model was then constructed with perceived quality of care as the outcome variable, patient 
engagement as the independent variable, and patient-centered care and family-centered care as 
the two moderators. Model 2 was selected, and 2000 bootstrap samples were utilized with all 
95% confidence intervals being bias corrected. Patient engagement, patient-centered care, and 
family-centered care were mean centered and heteroscedasticity-consistent standard errors were 
utilized. Mean centering the predictor and moderating variables allows for the examination of the 
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effect of one variable on the outcome at the mean level of the other variables in the model. The 
use of heteroscedasticity-consistent standard errors protects against any violations of the 
homoscedasticity assumption.  
The second model tested the moderating role of patient age on the relationship between 
patient engagement and perceived quality of care. In constructing this model, demographic or 
illness-related variables found to be significantly related to perceived quality of care were 
included as covariates, perceived quality of care was the outcome variable, patient engagement 
was the independent variable, and patient age was the moderator. For this analysis, Model 1 was 
selected, and 2000 bootstrap samples were calculated. All 95% confidence intervals were bias 
corrected, and patient engagement and patient age were mean-centered. Just as in the analysis 
above, heteroscedasticity-consistent standard errors were calculated to protect against any 
violation of the homoscedasticity assumption. Because this model has only one moderator, the 
Johnson-Neyman method was also utilized to determine the zone of significance for the 
moderator. In other words, if patient age is a significant moderator, the Johnson-Neyman method 
displays at what age the relationship between patient engagement and perceived quality of care 
significantly changes. 
The final moderation model tested the moderating roles of cognitive development and 
transitional readiness on the relationship between patient engagement and perceived quality of 
care. Demographic and illness-related characteristics found to be significantly related to 
perceived quality of care were included as covariates, and PROCESS Model 2 was chosen as the 
model. Perceived quality of care was the outcome variable, patient engagement was the 
independent variable, and cognitive development and transitional readiness were included as 
moderators. Two thousand bootstrap samples and 95% bias corrected confidence intervals were 
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calculated. Patient engagement, cognitive development, and transitional readiness were mean 
centered and heteroscedasticity-consistent standard errors were calculated.  
 The main limitation of the PROCESS macro for testing moderation is the inability to 
include more than one independent variable in the same model. Therefore, if there were no 
significant interactions found in the previous 3 models, a multiple linear regression model will be 
tested to examine the relationships between each of the main variables of interest (patient 
engagement, patient-centered care, family-centered care, patient age, cognitive development, and 
transitional readiness) and perceived quality of care. Demographic and illness-related 
characteristics found to be significantly related to perceived quality of care were included as 
control variables in the first model, and the main variables of interest were added in the second 
model.  
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Chapter 5 
Results 
 Overall, a total of 81 individuals were recruited for this study, and one was eliminated 
due to missing more than 25% of their data. Individual items and variables were analyzed for 
missing data. Based on cutoffs described in the data analysis section above, a total sample size of 
80 indicates that an individual item will be eliminated if more than 8 participants do not answer 
it. No items met this cutoff and, therefore, all items were retained. All variables had at least 4 
items, so all variables were retained in the analyses. Next, individual participants were examined 
to see if they were missing more than two items in a single variable. Two participants were 
missing data on more than two items for a specific variable, and as such, their scores were not 
included in analyses that included those variables. Finally, the main study variables were 
analyzed, and if more than 8 individuals were missing scores, the variables were eliminated. No 
variables met this cutoff and all were included in the following analyses. 
Demographic Characteristics 
 Information was collected on demographic characteristics and illness-related variables for 
each participant. Table 2 displays the demographic characteristics of the study sample. Overall, 
participants were an average of 15.68 (SD = 2.87) years old and had completed 9th grade. The 
sample had more male participants (N = 46; 57.5%) than female participants (N = 34; 42.5%), 
and was relatively diverse in terms of racial and ethnic background; sixty-one percent of the 
sample was white and 39 percent of the sample was from an ethnic minority background. Table 3 
displays information regarding the illness characteristics of the study sample. As can be seen in 
the table, the primary cancer diagnoses included leukemia or lymphoma (N = 47; 59.5%); bone 
tumors (N = 15; 19.0%); and soft tissue and Kaposi sarcomas (N = 8; 10.1%). On average, 
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participants were 13.68 (SD = 3.18) years of age at their first cancer diagnosis, and most 
participants received chemotherapy (N = 78; 97.5%) or surgery (N = 41; 51.2%) as a part of their 
treatment. Sixty-six percent of participants received more than one form of treatment for their 
cancer. The sample was relatively evenly split between participants who were receiving active 
treatment for their cancer (N = 42; 52.5%) and those who had completed active treatment (N = 
38; 47.5%), and 21 percent of participants had experienced a recurrence of their cancer.   
 Because participants were recruited from two different hospitals, participants from each 
hospital were compared on the main study variables to determine if there were significant 
differences due to the varying recruitment techniques used at each site. There were no significant 
differences on any of the main variables of interest between the two hospitals. The variables 
examined included quality of care, patient engagement, patient-centered care, family-centered 
care, patient age, cognitive development, and transitional readiness. Therefore, hospital location 
was not included as a control variable in subsequent analyses, and participants treated at either 
hospital were examined together, in aggregate. 
 Finally, t-tests, ANOVAs, and Pearson correlations were utilized to evaluate any 
significant differences in perceived quality of care based on demographic and illness 
characteristics in the current sample. Table 4 displays the results of these bivariate tests with 
categorical variables, and Table 5 displays the correlation matrix. Due to the small sample sizes 
in some of the groups analyzed in the categorical analyses, specifically for the race and diagnosis 
variables, recoded variables were also analyzed for variation in perceived quality of care based 
on demographics. Race was recoded to compare individuals indicating a race of White and 
individuals indicating a race other than White. There were no significant differences in perceived 
quality of care based on the recoded race variable (t (78) = 0.57, p = 0.57). Diagnosis was 
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recoded to compare individuals with leukemia or lymphoma, individuals with bone tumors, 
individuals with soft tissue sarcomas, and individuals with all other cancer diagnoses. There 
were significant differences in perceived quality of care based on the recoded diagnosis variable 
(F(3,76) = 4.16, p = 0.009). The remaining demographic and illness characteristics were not 
significantly related to perceived quality of care. Therefore, only diagnosis was included as a 
control variable in all analyses examining perceived quality of care. 
Descriptive Statistics of Study Variables 
Means, standard deviations, and ranges were calculated for each main study variable and 
can be found in Table 6. Overall, participants reported high perceived quality of care (M = 14.88; 
SD = 1.65) and engagement in their care (M = 16.24; SD = 3.21). Participants reported 
experiencing both patient-centered care (M = 29.35; SD = 3.88) and family-centered care (M = 
21.69; SD = 3.00). In relation to their development, participants were moderately ready to 
assume the independence of adulthood (Transitional Readiness M = 4.78; SD = 1.99), and 
reported a moderate level of cognitive autonomy (M = 43.76; SD = 6.65). 
Research Question 1 and Hypothesis 1 
 The first research question and its hypothesis aimed to examine the relationship between 
patient engagement and perceived quality of care. Patient engagement and perceived quality of 
care were not significantly correlated with each other at the bivariate level (r = .13, p = .24). A 
full correlation matrix examining the bivariate relationships between the main study variables 
can be found in Table 7. 
 Prior to interpreting the regression results, regression diagnostics were conducted. First, 
outliers or cases that may cause undue influence on the model were analyzed through a number 
of different mechanisms. The standardized residuals were analyzed, and only one residual was 
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greater than 3.29. Additionally, when looking at the larger standardized residuals as a whole, no 
more than 5% of the cases had values greater than 1.96. Cook’s distance, which measures if a 
single case has an undue influence on the model, was calculated for all participants, and none 
exceeded the cutoff of 1. Mahalanobis Distance was calculated, and although a few cases had 
borderline problematic values (Mahalanobis distances greater than 11), these cases were not 
significant concerns when analyzing other metrics for outliers so they were considered to be 
okay for inclusion in the model. The standardized DFBeta was analyzed to determine if any case 
substantially influenced the model parameters, and two values were larger than the cutoff of 1. 
However, these cases were not significant concerns when analyzing other metrics for outliers so 
they were considered to be okay for inclusion in the model. Taken together, no case was 
considered an outlier, and all cases were retained for the analysis. Finally, multicollinearity was 
evaluated through VIF values, and none of the values were above the cutoff of 2.50. Taken 
together, there were no significant outliers and the assumptions were not violated, so no changes 
were made to the model. 
The overall regression model significantly explained 14 percent of the variance in 
perceived quality of care (R2 = .14, p = .02). However, the inclusion of patient engagement in the 
second model did not improve the overall variance explained over and above the variance 
explained by cancer diagnosis (ΔR2 = .003, p = .63). The full regression model can be found in 
Table 8. It was hypothesized that adolescents with higher levels of patient engagement would 
perceive higher quality of care. However, the findings of these analyses do not support 
Hypothesis 1. 
Research Question 2 and Hypothesis 2 
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 The second research question and hypothesis examined the frequency of patient-centered 
care and family-centered care in the adolescent oncology setting. Participants reported 
experiencing both patient-centered and family-centered care very often (Patient-Centered Care M 
= 29.35, SD = 3.88; Family-Centered Care M = 21.69, SD = 3.00). In order to determine the 
frequency at which participants experienced each type of care, participants were categorized into 
experiencing each model of care or not. A cutoff score was established for each model of care, 
and this score was equivalent to participants indicating that they experience each item at least 
“most of the time.” Most participants experienced each model of care most of the time; six 
participants (7.5%) indicated not experiencing patient-centered care most of the time and 8 
participants (10.0%) indicated not experiencing family-centered care. Overall, this indicates that 
adolescent cancer patients experience patient-centered care more often than family-centered care, 
however, the majority of participants indicated experiencing both models of care. Hypothesis 2 
predicted that adolescents would experience family-centered care more often than patient-
centered care. The findings of these analyses do not support Hypothesis 2, but in fact suggest the 
opposite, that adolescent patients experience patient-centered care more frequently. 
Research Question 3 and Hypotheses 3a, 3b, 3c, and 3d 
 The third research question and its accompanying hypotheses aimed to examine if the 
frequency of patient-centered care and family-centered care varied based on the patient’s age or 
developmental stage. The full correlation matrix can be found in Table 7. Overall, patient-
centered care and family-centered care did not significantly vary as a function of age (patient-
centered care: r = .04 p = .76; family-centered care: r = .14, p = .22). Additionally, neither 
patient-centered care nor family-centered care varied as a function of cognitive development (r = 
.20 p = .07; family-centered care: r = .19, p = .10) or transitional readiness (r = .09 p = .42; 
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family-centered care: r = .19, p = .09). Hypothesis 3a predicted that patient-centered care would 
increase as adolescents got older, however the current findings did not support this. Hypothesis 
3b predicted that family-centered care would decrease as adolescents got older, however the 
current findings did not support this. Hypothesis 3c predicted that patient-centered care would 
increase as developmental stage increased. This hypothesis was not supported by the current 
findings. Hypothesis 3d predicted that family-centered care would decrease as adolescents’ 
developmental stage increased, but the findings of the current study did not support this. 
 There are differences as a function of development and model of care in patient 
engagement. Specifically, patient engagement increased as a function of experiencing family-
centered care (r = .25, p = .03) and cognitive development (r = .27, p = .02). With significant 
correlations found between patient engagement, the two models of care, and the developmental 
measures, a moderation framework was analyzed utilizing the PROCESS macro. The full 
moderation analyses can be found in Table 9. 
 The first model tested the moderating roles of cognitive development and transitional 
readiness on the relationship between patient-centered care and patient engagement. Overall, this 
model explained a significant portion of the variance in patient engagement (R2 = 0.11, p = 
0.05), and there was a significant main effect of cognitive development on patient engagement (b 
= 0.12, 95% CI [0.01, 0.23], p = .03). However, there were no significant interaction effects, 
indicating that neither cognitive development nor transitional readiness moderated the 
relationship between patient-centered care and patient engagement. 
The second model tested the moderating roles of cognitive development and transitional 
readiness on the relationship between family-centered care and patient engagement. This model 
explained a significant portion of the variance in patient engagement (R2 = 0.14, p = 0.02). Just 
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as in the previous model examining patient-centered care, cognitive development was the only 
significant predictor of patient engagement (b = 0.13, 95% CI [0.03, 0.23], p = .01). There were 
no significant interaction effects, indicating that neither cognitive development nor transitional 
readiness moderated the relationship between family-centered care and patient engagement. 
The PROCESS macro does not allow for the examination of more than one independent 
variable in its moderation analyses. Because the above analyses did not find any significant 
interaction effects, but in both models cognitive development was a significant, unique predictor 
of patient engagement, an additional multiple linear regression model was analyzed to examine 
the role of all four variables together. The results of this regression analysis can be found in 
Table 10. Overall, the model explained a significant portion of the variance in patient 
engagement (R2 = 0.13, p = .04), and only cognitive development was a significant unique 
predictor of patient engagement (b = 0.12, 95% CI [0.01, 0.23], p = .03). 
Research Question 4 
 The fourth research question explored if the relationship between patient engagement and 
perceived quality of care was moderated by patient-centered care, family-centered care, age, 
and/or developmental stage. Table 7 displays the correlation matrix between all of the study 
variables of interest. As can be seen in this table, perceived quality of care was positively 
correlated with patient-centered care (r = .54, p < .001), family-centered care (r = .46, p < .001), 
and cognitive development (r = .33, p = .003). Patient engagement was also positively correlated 
with family-centered care (r = .25, p = .03) and cognitive development (r = .27, p = .02). 
Although not all of the hypothesized relationships were significant, all of the proposed 
moderation analyses were conducted. 
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 The PROCESS macro for SPSS was utilized to conduct the moderation analyses. The 
final results for each model can be found in Table 11. The first model tested the moderating roles 
of patient-centered care and family-centered care on the relationship between patient engagement 
and perceived quality of care. This model explained 39 percent of the variance in perceived 
quality of care (R2 = 0.39, p = 0.03), but there were no significant main effects or interaction 
effects in this model. Therefore, patient-centered care and family-centered care did not moderate 
the relationship between patient engagement and perceived quality of care. 
 The second model tested the moderating role of age on the relationship between patient 
engagement and perceived quality of care. This model explained very little of the variance in 
perceived quality of care (R2 = 0.13, p = 0.29), and there were no significant main effects or 
interaction effects in this model. Therefore, patient age did not moderate the relationship 
between patient engagement and perceived quality of care. 
 The third model tested the moderating roles of cognitive development and transitional 
readiness on the relationship between patient engagement and perceived quality of care. This 
model explained very little of the variance in perceived quality of care (R2 = 0.20, p = 0.13), but 
there was a significant main effect of cognitive development on perceived quality of care (b = 
0.06, 95% CI [0.001, 0.12], p = .05). There were not any significant interaction effects in this 
model. Therefore, cognitive development and transitional readiness did not moderate the 
relationship between patient engagement and perceived quality of care. 
The PROCESS macro does not allow for the examination of more than one independent 
variable in its moderation analyses. Because the above analyses did not find any significant 
interaction effects, an additional multiple linear regression model was analyzed to examine the 
role of all six variables together. The results of this regression analysis can be found in Table 12. 
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Overall, the model explained a significant portion of the variance in perceived quality of care (R2 
= 0.40, p < .001), and the inclusion of the six main variables of interest improved the variance of 
perceived quality of care explained over and above cancer diagnosis (ΔR2 = .27, p < .001). Both 
patient-centered care (b = 0.15, 95% CI [0.03, 0.27], p = .02) and cognitive development (b = 
0.06, 95% CI [0.01, 0.11], p = .03) emerged as significant, unique predictors.  
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Chapter 6 
Discussion 
 The purpose of this study was to examine the experiences of adolescent cancer patients 
within the oncology setting, and elucidate variations in patient engagement, models of care, and 
development across this population. In contrast to the hypothesized relationship, patient 
engagement did not significantly predict quality of care in this sample of adolescent cancer 
patients. Instead, patient-centered care was a significant, unique predictor of perceived quality of 
care, highlighting the importance of the doctor-patient relationship to adolescent cancer patients. 
Additionally, cognitive development emerged as an important developmental milestone in 
relation to adolescents’ ability to engage in their healthcare and perceive differences in quality of 
care. The results also found no significant differences in quality of care or patient engagement 
based on the patient’s chronological age. This exemplifies the importance of considering 
development separate from age. Overall, the results of this study reiterate the necessity of 
examining adolescent cancer patients separate from their younger and older counterparts, and 
that the cognitive skills they are developing across this developmental period are important 
milestones in relation to their cancer experience. The remainder of the discussion will focus on 
the main study findings, the larger implications of this study within the context of the current 
literature, the main study limitations, and the significance of this work and future directions. 
Main Study Findings 
 Research question 1. The first research question examined the relationship between 
patient engagement and perceived quality of care. It was hypothesized that as patient engagement 
increased, participants would perceive higher quality of care. The findings of the current study 
 51 
 
did not support this hypothesis as there was not a significant relationship between patient 
engagement and perceived quality of care. 
 Patient engagement has not been examined in adolescent cancer patients, but the current 
findings do contradict the current literature on patient engagement in the adult healthcare 
literature (Hibbard & Greene, 2013). An intervention conducted with adult patients who utilize 
an online medication record to manage at least five medications provided patients the 
opportunity to log into their electronic medication records, screen the information for accuracy, 
and communicate any errors or concerns with their pharmacist (de Jong, Ros, van Leeuwen, & 
Schrijvers, 2016). Individuals who used the patient portal reported significantly more 
collaborative relationships with their pharmacist as compared to non-users (de Jong et al., 2016). 
Gagliardi et al. (2016) conducted a systematic review of interventions aimed at increasing patient 
engagement in arthritis and cancer patients. They reviewed a total of 16 interventions, and 6 
studies focused on cancer patients found improvements in decisional conflict, intention, anxiety, 
and satisfaction with treatment choice following the interventions. With the literature supporting 
the importance of patient engagement in quality of care, the Institute of Medicine (2013) placed 
an important emphasis on the development of patient engagement in their framework of high 
quality cancer care. As outlined in the introduction, however, it is potentially problematic to 
make sweeping suggestions for all cancer patients. The findings of the current study suggest that 
patient engagement does not play the same role in perceived quality of care in adolescent 
patients as it does in adult patients. 
 Research question 2. The second research question examined the frequency of each 
model of the doctor-patient relationship, and hypothesized that family-centered care would be 
experienced more frequently than patient-centered care. This hypothesis was not supported, and 
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in fact, the opposite was found to be true. Although, overall, participants reported experiencing 
both patient-centered and family-centered care at high rates, more participants endorsed 
experiencing patient-centered care. Adolescent cancer patients express a desire for information 
(Stinson et al., 2012; Zwaanswijk et al., 2007), and a role in decision-making (Dunsmore & 
Quine, 1995; Hinds et al., 2005; Stinson et al., 2012; Zwaanswijk et al., 2007). Patient-centered 
care focuses on accurate information provision, shared decision-making, and respect of patients’ 
values and preferences (Saha et al., 2008). Therefore, the increased experience of patient-
centered care in this sample of adolescent cancer patients indicates that pediatric oncologists and 
other members of the cancer care team are recognizing these desires in adolescent cancer 
patients, and interacting with them accordingly. It is important to note that the patient-centered 
care and family-centered care measures were highly correlated with each other. This may 
indicate that these two scales were measuring a similar construct. Further analysis is necessary to 
determine the exact constructs being measured with these items. 
 The increased experience of patient-centered care in the adolescent oncology setting, and, 
as such, an increased role in their own care, is supported by the literature on transition healthcare 
for adolescents with special healthcare needs (Holmes-Walker et al., 2007; McDonagh et al., 
2007; Tuchman et al., 2008). When adolescents with special healthcare needs do not, over time, 
begin to self-manage their healthcare and transition into the adult healthcare setting with the 
support of their healthcare provider, they report distress, anxiety, lack of health insurance, and 
lower standards of care for minority patients (Al-Yateem, 2013; Anderson, Flume, Hardy, & 
Gray, 2002; Flume, Taylor, Anderson, Gray, & Turner, 2004; Houtrow & Newacheck, 2008; 
Lotstein, Inkelas, Hays, Halfon, & Brook, 2008; Lotstein et al., 2009; Lotstein, Kuo, Strickland, 
& Tait, 2010; Lugasi, Achille, & Stevenson, 2011; Okumura et al., 2010; Peter, Forke, Ginsburg, 
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& Schwarz, 2009; Scal, Davern, Ireland, & Park, 2008; Scal & Ireland, 2005; Shaw, Southwood, 
& McDonagh, 2004; Watson, Parr, Joyce, May, & Le Couteur, 2011; Wong et al., 2010; Zack et 
al., 2003). Patient-centered care with its emphasis on shared decision-making and respect of the 
patients’ values and beliefs is a necessary component of helping adolescent cancer patients 
successfully transition into adult healthcare, when appropriate, and manage follow-up tests and 
care as they move into survivorship. 
 Research question 3. The third research question examined if the experience of patient-
centered or family-centered care varied as a function of patient age or developmental stage. The 
four accompanying hypotheses were not supported. Specifically, age was not significantly 
correlated with either patient-centered care (Hypothesis 3a) or family-centered care (Hypothesis 
3b). Patient-centered care did significantly increase as adolescents became more cognitively 
autonomous or prepared for the transition to adult healthcare (Hypothesis 3c). Finally, family-
centered care was not significantly associated with either cognitive development or transitional 
readiness (Hypothesis 3d). There were, however, variations in patient engagement as a function 
of models of care and development. Specifically, patient engagement increased as patients 
reported experiencing more family-centered care, and patient engagement increased as 
adolescents’ cognitive development increased. 
 The increase in patient engagement as the experience of family-centered care increases 
suggests that parents can provide an important supportive mechanism through which adolescents 
can be engaged in their care while also maintaining autonomy (Kuo et al., 2012).  Systematic 
literature reviews of family-centered interventions in pediatric and adolescent medical settings 
have found decreased family conflict, better use of health services, improvements in health 
status, and improvements in family functioning (Kuhlthau et al., 2011; McBroom & Enriquez, 
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2009). Providing adolescents with developmentally appropriate care in conjunction with more 
illness self-management is an important aspect of aiding adolescents in transitioning to adult 
healthcare, an area often found to be lacking in previous studies conducted with adolescents with 
special healthcare needs (AAP et al., 2011; Brooks, Bunn, & Morgan, 2009; Freed & Hudson, 
2006; Van Petegem, Beyers, Vansteenkiste, & Soenens, 2012).  
 To further understand the importance of development in understanding adolescent cancer 
patients’ interactions with their medical care, moderation and regression analyses found that 
cognitive development was the only unique predictor of patient engagement when examining 
developmental metrics and models of care. These findings reiterate the importance of examining 
developmental metrics among adolescent cancer patients, and that their ability to engage in their 
care is related to their ability to evaluate their actions and make thought-out decisions. 
Additionally, the differing patterns in associations among the developmental metrics analyzed 
and patient engagement suggests the need to measure more than one area of development; 
adolescent developmental research has found that individuals achieved different developmental 
milestones at varying times across the adolescent development period (Collins & Steinberg, 
2006; McNeely & Blanchard, 2009). Future research should also examine other important 
developmental metrics such as emotion regulation, changes in peer relationships, sensation-
seeking, and changes in the parent-child relationship. 
 Research question 4. The fourth research question explored how the relationship 
between patient engagement and perceived quality of care may be moderated by patient-centered 
care, family-centered care, patient age, and/or developmental stage. Patient engagement was not 
a significant predictor of perceived quality of care, and none of the examined moderating 
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variables were found to moderate the relationship between patient engagement and perceived 
quality of care.  
 Similar to the results from the first research question, patient engagement appears to play 
a different role among adolescent cancer patients than it does in adult patients. Additionally, both 
patient-centered care and cognitive development were significant predictors of perceived quality 
of care. The increase in experiencing patient-centered care and reported higher perceived quality 
of care aligns with previous research in adult cancer populations (Rathert et al., 2012). The 
positive relationship between cognitive development and perceived quality of care highlights the 
importance of a certain level of cognitive skills in an individual’s ability to perceive high quality 
care (Keating, 2012; McNeely & Blanchard, 2009; Overton, 1990; Spear, 2000; Steinberg, 
2009). The different pattern of relationships found in this population of adolescent cancer 
patients as compared to previous research with adult cancer patients suggests the need to further 
examine other possible variables (e.g. role in treatment decision-making, information provision, 
and the role of parents in the treatment experience) that may explain adolescents’ perceptions of 
the quality of care they receive.  
Quality of Care in Adolescent Oncology 
 Adolescents in the current study overwhelmingly perceived receiving high quality cancer 
care. The perception of high quality of care reported in the current sample may have been due to 
the data collection procedures. Specifically, adolescents were recruited in the exam rooms of the 
clinic they received their cancer care. The location of the survey may have caused adolescents to 
report more positive care than they otherwise would have. However, even in light of this 
limitation, there was still a small segment of the current sample that reported low levels of 
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quality of care. For those individuals whose care needs are still not met, we need to better 
elucidate what factors may be important to them when receiving cancer care.  
The Institute of Medicine (2013) placed the development of engaged patients at the 
center of their quality of cancer care framework, and a number of their priority recommendations 
focused on delivering accurate and understandable information, patient-centered care, and care 
that meets patients’ needs and values. It is unsurprising that these are the main components of 
their recommendations given that previous research has found numerous positive outcomes 
among patients receiving patient-centered care (Rathert et al., 2012). However, as outlined 
earlier, adolescents are a unique care group with their own needs and expectations. The findings 
of the current study supported the need to examine adolescents separately from adults, and found 
that patient engagement is not a main component of perceived quality of care from their 
perspective. The lack of variability in patient engagement and quality of care within this sample 
may be one reason for this lack of a significant relationship, but, this still begs the question, 
however, as to what are the important components of perceived quality of care for adolescent 
cancer patients. The current study provides a starting point for some possibilities, but further 
research is necessary. 
 Adolescents’ perceptions of their quality of care significantly increased as a function of 
experiencing patient-centered care and improved cognitive development skills. The significant 
relationship with patient-centered care may point to the importance of the doctor-patient 
relationship in adolescent oncology. Adolescents and young adults with cancer expressed the 
importance of having autonomy in decision-making around clinical trial participation, and the 
importance of having family and healthcare professionals as support systems in understanding 
the clinical trial (Pearce et al., 2016). Young adult survivors of childhood cancer who have 
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participated in survivorship care were more likely to understand the future health concerns they 
are at risk for as compared to survivors who have not participated in survivorship care (Ganju et 
al., 2016). Autonomous decision-making, supportive relationships, and appropriate information 
provision are all characteristics of patient-centered care. 
  Adolescent cancer patients also indicate a desire to be involved in treatment decision-
making (Hinds et al., 2005; Stinson et al., 2012; Zwaanswijk et al., 2007). However, neither the 
patient-centered care measure nor the quality of care measure included an item concerning the 
role of the patient in decision-making. Future research will need to ask specific, targeted 
questions concerning decision-making as that may be a more important component in adolescent 
cancer care than other aspects of patient-centered care. Similar to adults, adolescents also want 
doctor-patient relationships characterized by empathy, open communication, sufficient time with 
their doctor, and having their questions answered (Hinds et al., 2005; Zwaanswijk et al., 2007; 
Zwaanswijk et al., 2011). With the exception of a question concerning the amount of time spent 
with their doctor, the quality of care measure utilized in this study did not examine some of these 
aspects specifically. It may be that one of these specific characteristics is a more important 
indicator of quality than all of them as a whole. 
 The findings of these previous studies suggest that a more nuanced examination of the 
doctor-patient relationship may be necessary to elucidate what components of their care 
experience are predictors of higher quality of care in adolescent cancer survivors. The 
significant, positive relationship between perceived quality of care and cognitive development 
may also suggest the need for a certain level of cognitive autonomy in order to perceive high 
levels of quality of care. As discussed in the literature review, across adolescence, individuals 
begin to improve their reasoning skills and information processing abilities; improve their 
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abstract and hypothetical thinking; utilize foresight; plan ahead; improve their abstract and 
hypothetical thinking; utilize foresight; plan ahead; and set goals and achieve them (Collins & 
Steinberg, 2006; McNeely & Blanchard, 2009; Mello et al., 2009; Piaget 1972/2008). The 
emotion regulation processes necessary to interact in difficult situations with some level of logic 
and reason also develop across adolescence (Eluvanthigal et al., 2009). Developmental research 
suggests that it is important for adolescents to develop these skills within supportive parental and 
familial relationships (Benish-Weisman et al., 2013; Grotevant & Cooper, 1998; Kagitcibasi, 
2013; Steinberg, 2001; Tamis-LeMonda et al., 2007). Therefore, the role and perspective of the 
patient’s parent may be an important source of information in gaining a better insight into the 
quality of cancer care received by adolescents. Adolescents’ coping strategies are related to the 
coping strategies of their parents (Sanjari et al., 2008), and parents may be better able to describe 
some of the more nuanced aspects of cancer care, particularly for young adolescents still 
developing important cognitive skills. Patient engagement is an important aspect of quality of 
care in adult cancer populations, but the findings of the current study do not suggest the same 
relationship in adolescent cancer populations. Instead, other aspects of the doctor-patient 
relationship or the cognitive abilities of adolescents may be important mechanisms to improving 
quality of cancer care for adolescents. 
Patient Engagement and Models of Care 
 The current study found some varying patterns in patient engagement based on models of 
care and development. Specifically, patient engagement was significantly correlated with family-
centered care and cognitive development, but not patient-centered or transitional readiness. 
Adolescents and young adults with cancer expressed the importance of having autonomy in 
decision-making around clinical trial participation, but also the importance of having family and 
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healthcare professionals as support systems in understanding the clinical trial (Pearce et al., 
2016). Family-centered care is characterized by the inclusion of the patient and their family 
members, and developmental research suggests that as adolescents develop important cognitive 
and psychosocial skills, the support of parents and other adults is necessary in the face of life-
threatening situations (Turner-Henson, 2005). Much like the above discussion concerning 
perceived quality of care, the findings of this study combined with this past literature suggest the 
need to explore more specific aspects of the doctor-patient relationship to better determine the 
mechanisms through which patient engagement can be improved. 
 Although family-centered care was significantly correlated with patient engagement, only 
cognitive development emerged as a significant, unique predictor of patient engagement in this 
sample of adolescent cancer patients. The cognitive development measure utilized in this study 
examined adolescents’ ability to evaluate their thinking and make sound decisions, both 
important skills to have in order to be engaged in your healthcare. Patient engagement is defined 
as an increase in “a patient’s knowledge, skills ability, and willingness to manage his or her own 
healthcare” (p.1; Health Policy Brief: Patient Engagement, 2013), and without the ability to think 
critically and make clear decisions, it would be unreasonable to expect an individual to possess 
the skills necessary to manage their own healthcare. Previous research suggests that adolescents, 
particularly those in middle adolescence and older, often have gained the cognitive skills 
necessary to engage in their healthcare (Billick, Burgert, Friberg, Downer, & Bruni-Solhkhah, 
2001; Halpern-Felsher & Cauffman, 2001; Weithorn & Campbell, 1982). Specifically, Billick et 
al. (2001) found that, overall, their sample of pediatric inpatients and outpatients were competent 
enough to consent to medical treatment at the age of 12. Weithorn and Campbell (1982) found 
that 14 year olds were just as competent in making informed treatment decisions as adults, but 
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that 9 year olds were less competent as compared to adults in making informed treatment 
decisions. Finally, Halpern-Felsher and Cauffman (2001) found that adolescents differed from 
adults in their ability to perform some, but not all, of the tasks associated with informed decision-
making including consideration of options, risks, and long-term consequences. It is imperative 
that oncologists and other members of the cancer care team continue to recognize the importance 
of cognitive development, and provide care commensurate with adolescents’ cognitive abilities. 
The findings of this study suggest that oncologists and members of the care team do recognize 
this as patient-centered care was positively related to cognitive development, and more 
adolescents endorsed experiencing patient-centered care than family-centered care. Overall, the 
current study highlights the importance of providing care that is commensurate with adolescents’ 
developmental abilities, and that we need a more detailed examination of the specific behaviors 
healthcare providers utilize to help foster patient engagement in adolescent cancer patients. 
Importance of Multiple Developmental Metrics 
 A primary aim of the current study was to examine the role of development in the 
experience of adolescent cancer patients, as most studies focused on adolescent cancer patients 
do not measure development (Siembida & Bellizzi, 2015). The current findings clearly 
demonstrate the importance of examining development within adolescent oncology. Cognitive 
development was the only significant predictor of patient engagement and perceived quality of 
care, and was significantly correlated with patient-centered care. In contrast, transitional 
readiness was not significantly correlated with any of the main study variables. Both 
developmental metrics were significantly, positively related to age, as would be expected, but 
age was not significantly related to any other variable assessed in the current study. Although the 
developmental metrics were related to age, age did not play an important role in the other 
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characteristics of the cancer experience examined. In contrast, the developmental metrics did 
play an important role. This exemplifies the importance of considering development separate 
from age. 
 The differing relationships between cognitive development and transitional readiness and 
the other variables assessed in the current study highlights the importance of examining multiple 
metrics of development. Across adolescence, individuals gain important cognitive skills 
(Keating, 2012; McNeely & Blanchard, 2009; Overton, 1990; Spear, 2000; Steinberg, 2009), 
develop emotion regulation (Eluvathingal et al., 2007; Steinberg, 2009), renegotiate parent-child 
relationships (Benish-Weisman et al., 2013; Grotevant & Cooper, 1998; Kagitcibasi, 2013; 
Steinberg, 2001; Tamis-LeMonda et al., 2007), develop autonomy (Van Petegem et al., 2012), 
and prioritize peer and romantic relationships (Berger, 2005). All of these changes happen at 
different times across adolescent development (Collins & Steinberg, 2006; McNeely & 
Blanchard, 2009), indicating that at any point across this developmental period, an adolescent 
may be better equipped to handle some situations within their cancer treatment but not others. If 
the current study measured only transitional readiness, the importance of development in 
adolescent cancer patients would be greatly reduced; examining only one developmental metric 
would not provide the entire picture. 
Limitations 
 The conclusions of the current study should be interpreted in light of its limitations. First, 
the data described in this study was collected cross-sectionally utilizing in-person recruitment 
technique. The cross-sectional nature of the data precludes the ability to make any conclusions 
based on the causal effects of the significant relationships, and there is the possibility that the 
relationships are bi-directional. Additionally, the use of in-person recruitment techniques lead to 
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a high participation rate among the current sample, lending credence to the generalizability of the 
study’s findings. However, the act of taking the survey in the environment they received their 
care may prone participants to provide overly positive responses. This limitation may be one 
reason for the lack of significant relationships found in the current study. Finally, the lack of 
tailored measurement calls into question some of the conclusions of this study. The measures 
utilized in this study had satisfactory reliability, but few were developed specifically for use with 
adolescent cancer patients. The participants in this study expressed that some of the items did not 
apply to their experience. There is a clear need for measures developed and validated within the 
adolescent cancer population to better examine these important constructs. 
Conclusions and Future Research Directions 
The current study analyzed one of the largest samples of adolescent cancer patients found 
in the current literature. Previous research suggests that adolescent cancer patients are unique 
from their older and younger counterparts (Siembida & Bellizzi, 2015), and examination of this 
cancer population was warranted. The current study found that patient engagement was not a 
significant predictor of higher perceived quality of care, an important finding given the Institute 
of Medicine’s (2013) focus on increasing patient engagement as the first step to improving 
quality cancer care. 
 The lack of focus on development within the adolescent oncology literature was also a 
major barrier to a better understanding of the best care for this population (Siembida & Bellizzi, 
2015). Adolescent cancer patients previously reported their desire for developmentally 
appropriate information (Stinson et al., 2012; Zwaanswijk et al., 2007), and recognize that their 
preferences and roles will change as they mature (Hinds et al., 2005; Zwaanswijk et al., 2007). 
The current study aimed to fill this gap by examining two developmental metrics: cognitive 
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development and transitional readiness. The findings of this study provide important information 
regarding the role of development in adolescent cancer patient’s experience of their cancer care. 
Cognitive development was a significant predictor of perceived quality of care and patient 
engagement in the current study; however, transitional readiness was not. Differing patterns in 
the associations between development and models of care were also found. Taken together, these 
findings demonstrate the variations in multiple areas of development among adolescents. 
Developmental literature has found that adolescents mature at varying rates within different 
developmental milestones (Collins & Steinberg, 2006; McNeely & Blanchard, 2009), and the 
findings of this study concur. The need to examine multiple measures of development among 
adolescent cancer patients is clear, and brief screening measures for use within the adolescent 
oncology clinic setting need to be developed for ease of identification of cognitive 
developmental skills. The developed screening measure will need to be quick and efficient due to 
the time limitations places upon each adolescent’s clinic visit. The development of such a 
screening measure is an important next step in this work due to the lack of a significant 
relationship between chronological age and quality of care, reiterating that age cannot be used as 
a proxy for development. 
 Although the findings of this study answer some important questions for the adolescent 
cancer population, they are only a small part of what needs to be done to better provide 
adolescent cancer patients with high quality cancer care. The lack of a significant relationship 
between patient engagement and perceived quality of care in the current study suggests that 
adolescents may view quality of care differently than their adult counterparts. Future research 
will need to explore alternative mechanisms for improving care within this population. 
Additionally, the importance of development within these findings highlights the need for a 
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better understanding of individual patient’s developmental stage. The creation and evaluation of 
developmental screening measures or other tools will be an important step in aiding clinicians in 
providing appropriate care to adolescent cancer patients. Finally, this study examines the 
perspective of the adolescent cancer patient. However, their perspective is not the whole story, 
and the need for research examining the perspectives of parents and medical providers is needed. 
Steinberg and Lerner (2004) said “adolescents represent, at any point in history, the 
generational cohort that must next be prepared to assume the quality of leadership of self, family, 
community, and society that will maintain and improve human life” (p. 52). The medical 
advancements in cancer treatment have allowed for a whole new segment of the adolescent 
population to live long into adulthood, providing them an increased opportunity for providing 
this leadership. However, cancer care providers need to recognize the increased, autonomous 
role these adolescents desire to play to in their medical treatment, and we need to continue to 
respect the unique characteristics of adolescents and continue to alter their care across this 
developmental period. 
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Table 1. 
Demographic characteristics of pre-testing focus group 
 
Participant Gender Age 
(years) 
Grade Race Previous 
Chronic Illness 
History 
Time It Took to 
Complete Survey 
(minutes : seconds) 
1 Female 11 6 White None 7:34 
2 Female 10 5 White ADHD/ADD 12:43 
3 Male 12 6 White None 13:53 
4 Male 17 12 White Diabetes 10:13 
 
  
 66 
 
Table 2. 
Demographic characteristics of sample (N=80) 
 
Variable M 
(Range) 
SD N % 
Age 15.68 
(10 – 21) 
2.87   
Gender 
     Male 
     Female 
 
 
  
46 
34 
 
57.5 
42.5 
Education1 
     Grade 5 
     Grade 6 
     Grade 7 
     Grade 8 
     Grade 9 
     Grade 10 
     Grade 11 
     Grade 12 
     High school graduate 
     Some college courses 
     College graduate 
 
   
9 
1 
7 
5 
14 
9 
12 
3 
9 
11 
0 
 
11.3 
1.3 
8.8 
6.3 
17.5 
11.3 
15.0 
3.8 
11.3 
13.8 
0 
Racial/Ethnic Background 
     American Indian or Alaska Native 
     Asian 
     Black or African American 
     Hispanic or Latino 
     Native Hawaiian/Other Pacific Islander 
     White 
   
2 
3 
6 
20 
0 
49 
 
2.5 
3.8 
7.5 
25.0 
0 
61.3 
1Participants were instructed to indicate the highest grade in school that they have completed 
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Table 3. 
Illness-related characteristics of sample (N=80) 
 
Variable M 
(Range) 
SD N % 
Age at first diagnosis 13.68 
(5 – 20) 
3.18   
Diagnosis 
     Leukemia and lymphoma 
     Central nervous system tumor 
     Bone tumors 
     Soft tissue and Kaposi sarcoma 
     Germ cell cancer 
     Thyroid cancer 
     Melanoma of the skin 
     Other 
  
 
 
47 
4 
15 
8 
3 
0 
0 
2 
 
59.5 
5.1 
19.0 
10.1 
3.8 
0 
0 
2.5 
Treatment1 
     Chemotherapy 
     Radiation 
     Surgery 
     Bone marrow transplant 
     Other 
   
78 
36 
41 
5 
1 
 
97.5 
45.0 
51.2 
6.3 
1.3 
Receiving treatment 
     Yes 
     No 
   
42 
38 
 
52.5 
47.5 
Recurrence 
     Yes 
     No 
   
17 
63 
 
21.3 
78.8 
1Participants were instructed to choose all treatment options that applied to them, so the N’s will add up to more than 80 and the 
percentages will be greater than 100% 
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Table 4. 
Categorical demographic and illness-related characteristics and their association with quality of 
care (N=80) 
 
Variable t-test p 
Gender .79 .43 
Treatment Status -.10 .92 
Recurrence 1.31 .19 
Chemotherapy .98 .33 
Radiation .20 .84 
Surgery 1.35 .18 
Bone Marrow Transplant .10 .92 
Variable ANOVA p 
Racial/Ethnic Identity .90 .47 
Diagnosis 4.16 .009 
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Table 5. 
Continuous demographic and illness characteristics and their association with quality of care 
(N=80) 
 
Variable 1. 2. 3. 4. 
1. Quality of Care 1.00    
2. Grade .06 1.00   
3. Age -.003 .96** 1.00  
4. Age at Diagnosis .12 .71** .74** 1.00 
Note. ** = p < .001; * = p < .05  
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Table 6. 
Descriptive statistics of main study variables (N=80) 
 
Variable M SD Range Range of 
Possible Scores 
Quality of Care 14.88 1.65 9 – 16 4 – 16  
Patient Engagement 16.24 3.21 5 – 20 5 – 20  
Patient-Centered Care 29.35 3.88 8 – 32 0 – 32  
Family-Centered Care 21.69 3.00 9 – 24  0 – 24  
Cognitive Development 43.76 6.65 28 – 56 14 – 56  
Transitional Readiness 4.78 1.99 1 – 8 0 – 8  
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Table 7. 
Correlation matrix with main study variables (N=80) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. ** = p < .001; * = p < .05 
 
Variable 1 2 3 4 5 6 7 
1. Quality of Care 1.00       
2. Patient Engagement .13 1.00      
3. Age -.003 .04 1.00     
4. Patient-Centered Care .54** .21 .04 1.00    
5. Family-Centered Care .46** .25* .14 .73** 1.00   
6. Cognitive Development .33* .27* .33* .20 .19 1.00  
7. Transitional Readiness .07 -.02 .56** .09 .19 .21 1.00 
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Table 8. 
Multiple linear regression with quality of care as the dependent variable, 95% confidence 
intervals reported in parentheses (N=79) 
 
 B SE B t p 
Model 11     
     Constant 15.37 
(14.91, 15.83) 
.231 66.54 p < .001 
     Diagnosis1 -1.10 
(-2.03, -0.18) 
.466 -2.37 .02 
     Diagnosis2 -1.12 
(-2.32, 0.08) 
.60 -1.87 .07 
     Diagnosis3 -1.47 
(-2.56, -0.38) 
.55 -2.69 .01 
Model 2     
     Constant 14.91 
(14.91, 15.83) 
.99 15.08 p < .001 
     Diagnosis1 -1.07 
(-2.01, -0.13) 
.47 -2.26 .03 
     Diagnosis2 -1.09 
(-2.30, 0.12) 
.61 -1.80 .08 
     Diagnosis3 -1.42 
(-2.53, -0.30) 
.56 -2.53 .01 
     Patient Engagement 0.03 
(-0.09, 0.14) 
0.06 0.48 0.63 
Note. R2 = .14 for Model 1 (p = .01); R2 = .14 for Model 2 (p = .02) 
1Diagnosis1 = Bone Tumors vs. Leukemia/Lymphoma; Diagnosis2 = Soft Tissue Sarcomas vs. Leukemia/Lymphoma; 
Diagnosis3 = Other Diagnoses vs. Leukemia/Lymphoma  
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Table 9. 
PROCESS moderation models with patient engagement as the dependent variable, 95% 
confidence intervals reported in parentheses (N=78) 
 
 b SE B t p 
Model 1     
     Constant 16.24 
(15.51, 16.97) 
0.37 44.36 p  < .001 
     PCC1 (centered) 0.14 
(-0.04, 0.32) 
0.09 1.57 0.12 
     Cognitive Development (centered) 0.12 
(0.01, 0.23) 
0.05 2.21 0.03 
     Transitional Readiness (centered) -0.13 
(-0.57, 0.31) 
0.22 -0.60 0.55 
     PCC X Cognitive Development -0.01 
(-0.04, 0.03) 
0.02 -0.38 0.70 
     PCC X Transitional Readiness -0.02 
(-0.09, 0.13) 
0.06 0.31 0.76 
Model 2     
     Constant 16.30 
(15.59, 17.00) 
0.36 45.81 p < .001 
     FCC2 (centered) 0.21 
(-0.02, 0.43) 
0.11 1.79 0.08 
     Cognitive Development (centered) 0.13 
(0.03, 0.23) 
0.05 2.56 0.01 
     Transitional Readiness (centered) -0.17 
(-0.60, 0.27) 
0.22 -0.77 0.45 
     FCC X Cognitive Development -0.02 
(-0.05, 0.02) 
0.02 -1.00 0.32 
     FCC X Transitional Readiness -0.01 
(-0.13, 0.10) 
0.06 -0.19 0.85 
Note. R2 = .11 for Model 1 (p = .05); R2 = .14 for Model 2 (p = .02) 
1PCC = patient-centered care 
2FCC = family-centered care 
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Table 10. 
Multiple linear regression with patient engagement as the dependent variable, 95% confidence 
intervals reported in parentheses (N=78) 
 
 B SE B t p 
Model 1     
     Constant 6.56 
(-0.04, 13.15) 
3.31 1.98 0.05 
     PCC -0.01 
(-0.28, 0.26) 
0.13 -0.09 0.93 
     FCC 0.26 
(-0.09, 0.61) 
0.18 1.46 0.15 
     Cognitive Development 0.12 
(0.01, 0.23) 
0.06 2.23 0.03 
     Transitional Readiness -0.19 
(-0.56, 0.18) 
0.18 -1.03 0.31 
Note. R2 = .13 for Model 1 (p = .04) 
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Table 11. 
PROCESS moderation models with quality of care as the dependent variable, 95% confidence 
intervals reported in parentheses (N=78) 
 
 b SE B t p 
Model 11     
     Constant 15.26 
(14.65, 15.87) 
0.31 49.76 p  < .001 
     Patient Engagement (centered) -0.02 
(-0.16, 0.11) 
0.07 -0.35 0.73 
     PCC2 (centered) 0.19 
(-0.12, 0.49) 
0.15 1.21 0.23 
     FCC3 (centered) 0.05 
(-0.19, 0.29) 
0.12 0.45 0.65 
     PCC X Patient Engagement 0.04 
(-0.04, 0.12) 
0.04 0.97 0.34 
     FCC X Patient Engagement -0.04 
(-0.13, 0.04) 
0.04 -0.97 0.34 
     Diagnosis1 -1.01 
(-2.16, 0.13) 
0.57 -1.77 0.08 
     Diagnosis2 -0.83 
(-2.47, 0.82) 
0.82 -1.00 0.32 
     Diagnosis3 -0.97 
(-2.36, 0.42) 
0.70 -1.40 0.17 
Model 2     
     Constant 15.36 
(15.07, 15.65) 
0.15 105.62 p < .001 
     Patient Engagement (centered) 0.03 
(-0.08, 0.14) 
0.06 0.52 0.60 
     Age (centered) -0.01 
(-0.14, 0.11) 
0.06 -0.21 0.83 
     Age X Patient Engagement -0.004 
(-0.04, 0.03) 
0.02 -0.29 0.77 
     Diagnosis1 -0.92 
(-2.02, 0.18) 
0.55 -1.66 0.10 
     Diagnosis2 -1.10 
(-3.05, 0.85) 
0.98 -1.12 0.27 
     Diagnosis3 -1.42 
(-3.15, 0.32) 
0.87 -1.63 0.11 
Model 3     
     Constant 15.26 
(14.92, 15.60) 
0.17 89.23 p < .001 
     Patient Engagement (centered) 0.01 
(-0.13, 0.16) 
0.07 0.20 0.84 
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     Cognitive Development (centered) 0.06 
(0.001, 0.12) 
0.03 2.04 0.05 
     Transitional Readiness (centered) 0.02 
(-0.15, 0.18)  
0.08 0.20 0.84 
     Cognitive Development X Patient Engagement 0.004 
(-0.01, 0.02) 
0.01 0.41 0.68 
     Transitional Readiness X Patient Engagement -0.01 
(-0.09, 0.06) 
0.04 -0.37 0.71 
     Diagnosis1 -0.90 
(-1.97, 0.16) 
0.54 -1.69 0.10 
     Diagnosis2 -0.94 
(-2.93, 1.05) 
1.00 -0.94 0.35 
     Diagnosis3 -1.31 
(-2.89, 0.28) 
0.79 -1.65 0.10 
Note. R2 = .39 for Model 1 (p = .03); R2 = .13 for Model 2 (p = .29); R2 = .20 for Model 3 (p = .13) 
1Diagnosis1 = Bone Tumors vs. Leukemia/Lymphoma; Diagnosis2 = Soft Tissue Sarcomas vs. Leukemia/Lymphoma; 
Diagnosis3 = Other Diagnoses vs. Leukemia/Lymphoma 
2PCC = patient-centered care 
3FCC = family-centered care 
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Table 12. 
Multiple linear regression with quality of care as the dependent variable, 95% confidence 
intervals reported in parentheses (N=77) 
 
 B SE B t p 
Model 11     
     Constant 15.36 
(14.89, 15.82) 
.23 65.94 p < .001 
     Diagnosis1 -0.93 
(-1.88, 0.03) 
.48 -1.84 .06 
     Diagnosis2 -1.12 
(-2.30, 0.09) 
.60 -1.84 .07 
     Diagnosis3 -1.46 
(-2.54, -0.37) 
.55 -2.67 .01 
Model 2     
     Constant 8.45 
(4.91, 11.99) 
1.77 4.77 p < .001 
     Diagnosis1 -0.82 
(-1.67, 0.02) 
.42 -1.94 .06 
     Diagnosis2 -0.71 
(-1.76, 0.35) 
.53 -1.34 .19 
     Diagnosis3 -0.90 
(-1.89, 0.08) 
.49 -1.83 .07 
     Patient Engagement -0.05 
(-0.15, 0.06) 
0.05 -0.91 0.37 
     Transitional Readiness 0.05 
(-0.15, 0.24) 
0.10 0.47 0.64 
     Patient-Centered Care 0.15 
(0.03, 0.27) 
0.06 2.45 0.02 
     Family-Centered Care 0.09 
(-0.07, 0.25) 
0.08 1.09 0.28 
     Cognitive Development 0.06 
(0.01, 0.11) 
0.03 2.22 0.03 
     Age -0.09 
(-0.23, 0.04) 
0.07 -1.37 0.17 
Note. R2 = .13 for Model 1 (p = .02); R2 = .40 for Model 2 (p < .001) 
1Diagnosis1 = Bone Tumors vs. Leukemia/Lymphoma; Diagnosis2 = Soft Tissue Sarcomas vs. Leukemia/Lymphoma; 
Diagnosis3 = Other Diagnoses vs. Leukemia/Lymphoma  
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Figure 1. 
Comparison of the constructs of patient-centered and family-centered care 
 
 
  
Patient-
Centered Care
Provision of 
information and 
preventative healthcare
Focus on shared 
decision making
Consideration of the 
patient's environment
Understanding and 
respecting patient's 
values, beliefs, and 
preferences
Family-
Centered Care
Provide objective and 
unbiased information
Decisions are 
approached with 
shared goals in mind
Consider that all 
treatment is conducted 
within the patient's 
environment
Great amount of 
diversity in culture and 
preferences, and 
respecting this diversity
All treatment decisions 
are open to negotiation
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Figure 2. 
Flowchart describing recruitment of adolescent cancer patients for the current study 
 
  
Total Eligible Participants 
N = 97 
Attended clinic 
appointment 
N = 92 
Clinic Appointment 
Cancelled 
N = 5 
Approached for study 
N = 86 
Research staff unable to 
approach 
N = 6 
Consented to study 
N = 82 
Refused 
N = 4 
Completed survey 
N = 81 
Dropped out following 
consent 
N = 1 
 Participation rate based on total eligible participants: 81/97 = 83.5% 
 Participation rate based on eligible participants, approached: 81/86 = 94.2% 
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Appendix A 
 
Institute of Medicine’s (2013) conceptual framework for high quality cancer care 
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Appendix B 
Study Conceptual Model 
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Appendix C 
Recruitment Flyers 
 
Research Study 
Smilow Cancer Hospital at Yale-New Haven 
Connecticut Children’s Medical Center 
and  
The Department of Human Development and Family Studies at the University of 
Connecticut 
Who is Eligible? 
 Adolescents diagnosed with cancer between the ages of 10 and 20 
 Cancer diagnosis was at least 3 months ago 
 Either receiving active treatment or have finished with active treatment for no more than 
2 years 
 Must be able to speak and read English 
 
What will you be asked to do? 
 Fill out an online survey 
 You will receive an email with your survey link and can complete it at a convenient time 
 The survey should take no more than 20 minutes to complete 
Will I get anything for participation? 
 You will receive a $20 Amazon gift card for completing the survey 
 
If you have any questions or are interested in participating,  
please contact: 
Elizabeth Siembida (Project Manager) at 860-375-4138 or Email: 
elizabeth.siembida@uconn.edu
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Yale Pediatric Oncology Clinic 
Research Study 
We’re trying to make clinic better and want your feedback! 
Who is Eligible? 
 Adolescents diagnosed with cancer between the ages of 10 and 20 
 Cancer diagnosis was at least 3 months ago 
 Either receiving active treatment or have finished with active treatment for no more than 
2 years 
 Must be able to speak and read English 
 
What will you be asked to do? 
 Fill out an online survey 
 You will fill out the survey while visiting the clinic on an iPad or tablet OR you can 
choose to receive a survey link via email and complete it at a convenient time 
 The survey should take no more than 10-15 minutes to complete 
 
Will I get anything for participation? 
 You will receive a $20 Amazon gift card for completing the survey 
If you’re interested in participating while sitting in the waiting room, text “Adolescent Survey” 
to 774-230-1090 and a knowledgeable individual will come out and meet you. 
If you have any questions or are interested in participating at home, please contact: 
Elizabeth Siembida (Project Manager) at 774-230-1090 or Email: 
elizabeth.siembida@uconn.edu
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Appendix D 
Online Survey Introduction 
 
Patient Engagement and Quality of Care in Adolescent Oncology 
 
Thank you for your interest in taking part in this study. 
 
Your responses will be useful in examining adolescents' engagement in their cancer treatment, 
and how this engagement is related to the quality of care received during cancer treatment. 
 
You were directed to this survey because you are a patient at [Name of Hospital]. Your doctor 
believes that your responses to this survey will be useful in answering the questions of our 
research study. Before continuing to the survey, please be sure you fit the qualifying criteria: 
 
1. Diagnosed with cancer between the ages of 10 and 20 
2. Diagnosed with cancer at least 6 months ago 
3. Finished active treatment no more than 2 years ago 
 
If you fit the above criteria, please continue to the survey. Once you finish the survey, you will 
receive a $20 Amazon gift card as a thank you for your participation. 
 
Your participation in this survey is strictly voluntary. You are welcome to stop the survey at 
anytime, and if any question makes you uncomfortable, you are welcome to skip it. If you have 
additional questions about this study, please contact the Principal Investigator, Elizabeth 
Siembida at 774-230-1090 or elizabeth.siembida@uconn.edu. 
 
Thank you! 
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Appendix E 
Informed consent form from online survey 
 
A Developmental Examination of Patient Engagement and Quality of Care in Adolescent 
Oncology 
 
PARENT CONSENT 
 
Aim: To examine the relationship between patient engagement and quality of care in the 
adolescent oncology setting. 
 
Investigator(s): Dr. Kerry Moss (860) 545-9630 
   Elizabeth Siembida (774) 230-1090 
Purpose of the Research: 
Major medical organizations in the United States, like the American Society of Clinical 
Oncology and the Institute of Medicine, have emphasized the importance of improving the 
quality of cancer care in America, and one of the major areas of quality cancer care that needs 
attention is patient engagement. Patient engagement is a patient’s ability to understand and 
manage their own healthcare. Both organizations provide recommendations for improving 
patient engagement, but neither discusses the importance of considering how it may look 
different in adolescent patients. Therefore, we would like to examine the relationship between 
patient engagement and quality of care in adolescent cancer patients. We believe that the opinion 
of your child will help us to better understand patient engagement and what it looks like in 
adolescent cancer patients. 
Description of the Research: 
First, we will ask you (or your child) a few questions about your child. Then, we will show you 
and your child an electronic device that has the study survey on it. We will ask your child to 
complete the survey on the screen once. 
Your child will be asked to answer a series of questions, and we will explain how to complete 
the survey prior to your child starting it. This should take no longer than 20 minutes to complete. 
If you or your child have any questions someone from the study team will be available to you at 
this time to answer any questions that you may have. For this study we will be asking 103 
adolescents from different hospitals to participate.  
Potential Risks: 
There is a risk of a loss of confidentiality. We will protect against this by using a unique study 
number that will not contain any identifying information.  The questions that are answered on the 
electronic device will not have any identifying information. If there are any questions on the 
survey that make you or your child uncomfortable, you do not need to answer. 
 101 
 
Potential Benefits: 
To individual subjects: 
Your child will not benefit directly from participating in this study. 
A summary of the study results will be made available to you at the end of the study. 
 
To society:  
The study findings may provide valuable information and several benefits including helping 
doctors and nurses better understand how best to communicate with adolescent cancer patients. 
Confidentiality: 
 
Your responses (or your child’s responses) will be kept anonymous. The answers provided in 
this survey will not be associated with your child’s identifying information, and following the 
completion of the research study the data will be kept as long as needed to finish the study then 
destroyed. Published study results will not reveal who you or your child is/are. 
 
Reimbursement:  
Your child will get a $20 gift card for taking part in the study.  There will be no additional cost to 
you by being part of this study. 
 
Participation: 
Your decision for your child’s participation is voluntary. If you choose to let your child take part in this 
study you can take your child out of the study at any time. The medical care your child receives will not 
be affected in any way by whether your child takes part in this study. New information that we get while 
we are doing this study may affect your decision to take part in this study. If this happens, we will tell 
you about this new information. And we will ask you again if you still want to be in the study. 
 
Questions: 
The principal investigator, Dr. Kerry Moss, is willing to answer any questions you may have 
about the study, or address any concerns or complaints, and may be reached at (860) 545-9630.  
Future concerns or questions about this study also may be directed to Dr. Kerry Moss.  If you 
have questions about your child’s rights as a research subject, or if you would like to discuss 
problems, concerns, or questions, obtain information, or offer input about a particular research 
study, you may call the Institutional Review Board at Connecticut Children’s Medical Center at 
(860)545-9980.  In the event of research-related injury, please contact Dr. Kerry Moss at 860-
545-9630. 
 
 
By checking off the box below, I agree that I have read and understood the above study 
information, and I agree, or consent, that my child may take part in this study. 
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Appendix F 
Assent form from online survey 
 
A Developmental Examination of Patient Engagement and Quality of Care in Adolescent 
Oncology 
 
ASSENT FORM 
 
Aim: To find out adolescent’s involvement in their cancer treatment 
Principal Investigator:   Dr. Kerry Moss (860) 545-9630 
    Elizabeth Siembida (774)-230-1090 
Why are we doing this study? 
Medical organizations and doctors believe that good cancer care includes the patient’s 
involvement in their treatment. We want to see what this involvement looks like in adolescents 
diagnosed with cancer between the ages of 10 and 20. 
We hope the information that you give us will help to find out how adolescents are involved in 
their cancer treatment. 
What will happen during the study? 
After reading this page you will be asked to complete the survey on the screen once. You will be 
asked a series of questions, and we will explain how to complete the survey before you start. The 
survey will also include directions on how to complete it. This should take no longer than 20 
minutes to complete. 
Are there good things and bad things about the study? 
 The survey questions will ask you about you and your cancer treatment. If there are any questions that 
make you feel uncomfortable, you do not need to answer. 
Do you get anything for helping us with the study? 
We will give you a $20 gift card as a thank you for helping us with our study. 
Who will know about what I did in the study? 
Your answers to these questions will only be seen by the research team. We can use this information to 
help understand adolescents’ involvement in their cancer treatment. 
Can I decide if I want to be in the study? 
Nobody will be angry or upset if you do not want to be in the study. We are talking to your parent/legal 
guardians about the study and you should talk to them about it too. If you wish to stop the survey, you 
may exit it out any point. 
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If you still want to participate in this study, please check the box below. By checking the box 
below you agree, or assent, to take part in the study. 
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Appendix G 
Summary of Survey Pre-Testing Focus Group 
 
Survey 
Measure 
Were there any 
questions on this page 
that you had trouble 
understanding? 
Were there any 
response options on 
this page that you 
didn’t understand? 
What would make this 
question/response option 
easier to understand? 
Demographic 
Characteristics 
 No issues  No issues  
Patient 
Engagement 
 No issues  No issues  
Patient-
Centered and 
Family-
Centered Care 
 The following item was 
confusing: Look at all the 
needs of you and your 
family (for example, 
emotional or social needs) 
instead of just physical 
needs 
 Original response 
options (Never, +, ++, 
Sometimes, +++, 
++++, A lot, Does not 
apply to me) were hard 
to understand 
 
 Change the response options 
to: Never, Sometimes, Most of 
the time, All the time, Does 
not apply to me 
 Rearrange wording order to 
the following: Look at all the 
needs of you and your family 
instead of just physical needs 
(for example, emotional or 
social needs) 
Quality of Care  The following question 
was confusing: During 
cancer treatment, did you 
have a hard time speaking 
with or understanding 
your oncologist because 
you spoke different 
language. It was unclear 
the best way to answer 
when they speak the same 
language as their doctor 
 No issues  It was decided that it made 
sense to add ‘does not apply’ 
as a response option to this 
question 
Cognitive 
Autonomy 
 No issues  The response item 
‘seldom’ was hard to 
understand. 
 One participant 
reported having 
difficulty 
distinguishing 
‘sometimes’ from 
‘often.’ 
 Replaced ‘seldom’ with 
‘sometimes.’ 
 Since only one participant 
reported difficulty with ‘often,’ 
it was kept the same. 
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Survey 
Measure 
Were there any 
questions on this page 
that you had trouble 
understanding? 
Were there any 
response options on 
this page that you 
didn’t understand? 
What would make this 
question/response option 
easier to understand? 
 
Transitional 
Readiness 
 Confusion on question: 
Do you apply for a job or 
work or higher education 
 Thought that the use of 
home and room in the 
following item made the 
question difficult to 
understand: Do you keep 
home/room clean or 
clean-up after meals 
 Confusion on question: 
Do you call on and use 
community support 
services (Ex. Afterschool 
programs) and advocacy 
services (Ex. Legal 
services) when you need 
them 
 In asking questions 
with the participants, 
they were answering 
questions based on how 
often their parents 
would do one of the 
items instead of saying 
that they (the 
participant) does not do 
the item 
 Thought that a ‘does 
not apply’ option 
would be useful 
 Question reworded to: Do 
you apply for a job or college 
when needed? 
 Reworded question to: Do 
you keep house/bedroom clean 
or clean-up after meals? 
 The question regarding 
community services was 
eliminated 
 A response option was 
added to all questions in this 
measure that says ‘My 
parent/guardian does this.’ 
 A ‘does not apply’ option 
was added to a few questions 
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Appendix H 
Final Survey 
 
Online Survey Examining Doctor-Patient Relationships in Adolescent Cancer Patients 
 
BACKGROUND INFORMATION 
 
Please answer the following questions as best you can. You can also ask your parent or guardian 
for help if you are not sure what the right answer is. 
 
1. What is the highest grade in school that you have completed? 
a. Grade 5 
b. Grade 6 
c. Grade 7 
d. Grade 8 
e. Grade 9 
f. Grade 10 
g. Grade 11 
h. Grade 12 
i. High school graduate 
j. Some college courses 
k. College graduate 
 
2.  How old are you? (in years) 
 
3. Which of the following best describes your race? 
a. American Indian or Alaska Native 
b. Asian 
c. Black or African American 
d. Hispanic or Latino 
e. Native Hawaiian/Other Pacific Islander 
f. White 
 
4. What is your gender? 
a. Male 
b. Female 
c. Other 
 
5. Please list where you received your cancer treatment? 
a. Connecticut Children’s Medical Center 
b. Smilow Cancer Hospital at Yale-New Haven 
 
6. What was your primary cancer diagnosis? 
a. Leukemia and lymphoma 
b. Central nervous system tumor 
c. Bone tumors (e.g. osteosarcoma and Ewing’s sarcoma) 
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d. Soft tissue and Kaposi sarcoma 
e. Germ cell cancer (e.g. testicular cancer) 
f. Thyroid cancer 
g. Melanoma of the skin 
h. Other cancer (please describe) 
 
7. How old were you when you were diagnosed with cancer? (in years) 
 
8. What type of treatment did you receive for your cancer? (Check all that apply) 
a. Chemotherapy 
b. Radiation 
c. Surgery 
d. Bone marrow transplant 
e. Other (please describe) 
 
9. Are you currently receiving active treatment for your cancer? 
a. Yes 
b. No 
c. If no, when did you complete active treatment? 
 
10. Have you had a recurrence of your cancer? 
a. Yes 
b. No 
 
PATIENT ENGAGEMENT 
 
For each of the following statements, please choose the response option that represents your 
experience during cancer treatment. 
 
1. I will tell my oncologist my concerns, even if they do not ask. 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
 
2. I talk to my oncologist about different options to address health problems or concerns. 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
 
3. I make appointments for myself to see my oncologist. 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
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4. When I make a plan with my oncologist, I can follow through on the plan at home. 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
 
5. I have a safe and trusting relationship with at least one member of my cancer care team. 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
 
 
PATIENT-CENTERED AND FAMILY-CENTERED CARE 
 
Think about the doctors and nurses who have helped with your cancer treatment, and identify 
how often the following things happen (or do not happen) to you… 
 
1. Allow you to answer questions 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
2. Feel you can trust them 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
3. Show they care about you and your family 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
4. Give you and your parent(s) written information about your treatment 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
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5. Let you and your parent(s) choose when to receive information and what type of 
information you receive  
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
6. Talk to you honestly 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
7. Fully explain treatment choices to you and your family 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
8. Trust you know yourself best 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
9. Give you a chance to talk 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
10. Treat you as an individual 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
11. You and family have final say in treatment decisions 
a. Never 
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b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
12. Look at all the needs of you and your family instead of just physical needs (for example, 
emotional or social needs) 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
13. Understand your feelings 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
14. Give you a chance to say what you want 
a. Never 
b. Sometimes 
c. Most of the time 
d. All the time 
e. Does not apply to me 
 
QUALITY OF CARE 
 
For the following items, please select the response option that most closely resembles your 
experience during cancer treatment. 
 
1. During cancer treatment, did your oncologist or other members of your cancer care team 
listen carefully to you? 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
 
2. During cancer treatment, did you have a hard time speaking with or understanding your 
oncologist or other members of your cancer care team because you spoke different 
languages? 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
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e. Does not apply to me 
 
3. During cancer treatment, did your oncologist or other members of your cancer care team 
explain things in a way that you could understand? 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
 
4. During cancer treatment, did your oncologist or other members of your cancer care team 
show respect for what you had to say? 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
 
5. During cancer treatment, did your oncologist or other members of your cancer care team 
spend enough time with you? 
a. Strongly disagree 
b. Somewhat disagree 
c. Somewhat agree 
d. Strongly agree 
 
DEVELOPMENTAL STAGE 
 
For the following questions, please indicate how often you do each of the items. 
 
1. I think about the consequences of my decisions. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
2. I look at every situation from other people’s perspectives before making my own 
judgments. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
3. I think of all possible risks before acting on a situation 
a. Never 
b. Sometimes 
c. Often 
d. Always 
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4. I like to evaluate my daily actions. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
5. I consider alternatives before making decisions. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
6. I think about how my actions will affect others. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
7. I think about how my actions will affect me in the long run. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
8. I like to evaluate my thoughts. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
9. There are consequences to my decisions. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
10. I can tell that my way of thinking has improved with age. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
11. I think more about the future today than I did when I was younger. 
a. Never 
b. Sometimes 
c. Often 
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d. Always 
 
12. My decision making ability has improved with age. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
13. I am good at evaluating my feelings. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
14. I am better at decision making than my friends. 
a. Never 
b. Sometimes 
c. Often 
d. Always 
 
For each of the following statements, please choose the answer that represents your experience 
during your cancer treatment. 
 
1. Do you keep house/bedroom clean or clean-up after meals? 
a. Never 
b. Sometimes 
c. Often 
d. Always 
e. My parent/guardian does this 
 
2. Do you use neighborhood stores and services (Ex. Grocery stores or pharmacy stores)? 
a. Never 
b. Sometimes 
c. Often 
d. Always 
e. My parent/guardian does this 
 
3. Do you help prepare meals/food? 
a. Never 
b. Sometimes 
c. Often 
d. Always 
e. My parent/guardian does this 
 
4. Do you fill out the medical history form, including a list of your allergies? 
a. Never 
 114 
 
b. Sometimes 
c. Often 
d. Always 
e. My parent/guardian does this 
 
5. Do you keep a calendar or list of medical and other appointments? 
a. Never 
b. Sometimes 
c. Often 
d. Always 
e. My parent/guardian does this 
 
6. Do you request and get the accommodations and support you need at school or work? 
a. Never 
b. Sometimes 
c. Often 
d. Always 
e. My parent/guardian does this 
f. Does not apply to me 
 
7. Do you apply for a job or college when necessary? 
a. Never 
b. Sometimes 
c. Often 
d. Always 
e. My parent/guardian does this 
f. Does not apply to me 
 
8. Do you get financial help with school or work? 
a. Never 
b. Sometimes 
c. Often 
d. Always 
e. My parent/guardian does this 
f. Does not apply to me 
 
 
 
 
